KEid_target	KEid	AOPid_source	AOPid	AOPtitle
https://identifiers.org/aop.events/709	https://identifiers.org/aop.events/709	https://identifiers.org/aop/105	https://identifiers.org/aop/105	Alpha2u-microglobulin cytotoxicity leading to renal tubular adenomas and carcinomas (in male rat)
https://identifiers.org/aop.events/721	https://identifiers.org/aop.events/721	https://identifiers.org/aop/106	https://identifiers.org/aop/106	Chemical binding to tubulin in oocytes leading to aneuploid offspring
https://identifiers.org/aop.events/715	https://identifiers.org/aop.events/715	https://identifiers.org/aop/107	https://identifiers.org/aop/107	Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas in the mouse and the rat
https://identifiers.org/aop.events/1214	https://identifiers.org/aop.events/1214	https://identifiers.org/aop/107	https://identifiers.org/aop/107	Constitutive androstane receptor activation leading to hepatocellular adenomas and carcinomas in the mouse and the rat
https://identifiers.org/aop.events/209	https://identifiers.org/aop.events/209	https://identifiers.org/aop/108	https://identifiers.org/aop/108	Inhibition of pyruvate dehydrogenase kinase leading to hepatocellular adenomas and carcinomas (in mouse and rat)
https://identifiers.org/aop.events/277	https://identifiers.org/aop.events/277	https://identifiers.org/aop/110	https://identifiers.org/aop/110	Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse)
https://identifiers.org/aop.events/281	https://identifiers.org/aop.events/281	https://identifiers.org/aop/110	https://identifiers.org/aop/110	Inhibition of iodide pump activity leading to follicular cell adenomas and carcinomas (in rat and mouse)
https://identifiers.org/aop.events/149	https://identifiers.org/aop.events/149	https://identifiers.org/aop/115	https://identifiers.org/aop/115	Epithelial cytotoxicity leading to forestomach tumors (in mouse and rat)
https://identifiers.org/aop.events/277	https://identifiers.org/aop.events/277	https://identifiers.org/aop/119	https://identifiers.org/aop/119	Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse)
https://identifiers.org/aop.events/281	https://identifiers.org/aop.events/281	https://identifiers.org/aop/119	https://identifiers.org/aop/119	Inhibition of thyroid peroxidase leading to follicular cell adenomas and carcinomas (in rat and mouse)
https://identifiers.org/aop.events/52	https://identifiers.org/aop.events/52	https://identifiers.org/aop/12	https://identifiers.org/aop/12	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration with impairment in learning and memory in aging
https://identifiers.org/aop.events/55	https://identifiers.org/aop.events/55	https://identifiers.org/aop/12	https://identifiers.org/aop/12	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration with impairment in learning and memory in aging
https://identifiers.org/aop.events/201	https://identifiers.org/aop.events/201	https://identifiers.org/aop/12	https://identifiers.org/aop/12	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration with impairment in learning and memory in aging
https://identifiers.org/aop.events/352	https://identifiers.org/aop.events/352	https://identifiers.org/aop/12	https://identifiers.org/aop/12	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration with impairment in learning and memory in aging
https://identifiers.org/aop.events/381	https://identifiers.org/aop.events/381	https://identifiers.org/aop/12	https://identifiers.org/aop/12	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration with impairment in learning and memory in aging
https://identifiers.org/aop.events/188	https://identifiers.org/aop.events/188	https://identifiers.org/aop/12	https://identifiers.org/aop/12	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration with impairment in learning and memory in aging
https://identifiers.org/aop.events/195	https://identifiers.org/aop.events/195	https://identifiers.org/aop/12	https://identifiers.org/aop/12	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development leads to neurodegeneration with impairment in learning and memory in aging
https://identifiers.org/aop.events/277	https://identifiers.org/aop.events/277	https://identifiers.org/aop/128	https://identifiers.org/aop/128	Kidney dysfunction by decreased thyroid hormone
https://identifiers.org/aop.events/281	https://identifiers.org/aop.events/281	https://identifiers.org/aop/128	https://identifiers.org/aop/128	Kidney dysfunction by decreased thyroid hormone
https://identifiers.org/aop.events/814	https://identifiers.org/aop.events/814	https://identifiers.org/aop/128	https://identifiers.org/aop/128	Kidney dysfunction by decreased thyroid hormone
https://identifiers.org/aop.events/383	https://identifiers.org/aop.events/383	https://identifiers.org/aop/13	https://identifiers.org/aop/13	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities
https://identifiers.org/aop.events/382	https://identifiers.org/aop.events/382	https://identifiers.org/aop/13	https://identifiers.org/aop/13	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities
https://identifiers.org/aop.events/52	https://identifiers.org/aop.events/52	https://identifiers.org/aop/13	https://identifiers.org/aop/13	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities
https://identifiers.org/aop.events/381	https://identifiers.org/aop.events/381	https://identifiers.org/aop/13	https://identifiers.org/aop/13	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities
https://identifiers.org/aop.events/195	https://identifiers.org/aop.events/195	https://identifiers.org/aop/13	https://identifiers.org/aop/13	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities
https://identifiers.org/aop.events/201	https://identifiers.org/aop.events/201	https://identifiers.org/aop/13	https://identifiers.org/aop/13	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities
https://identifiers.org/aop.events/55	https://identifiers.org/aop.events/55	https://identifiers.org/aop/13	https://identifiers.org/aop/13	Chronic binding of antagonist to N-methyl-D-aspartate receptors (NMDARs) during brain development induces impairment of learning and memory abilities
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/130	https://identifiers.org/aop/130	Phospholipase A2 (LPLA2) inhibitors leading to hepatotoxicity
https://identifiers.org/aop.events/845	https://identifiers.org/aop.events/845	https://identifiers.org/aop/131	https://identifiers.org/aop/131	Aryl hydrocarbon receptor activation leading to uroporphyria
https://identifiers.org/aop.events/850	https://identifiers.org/aop.events/850	https://identifiers.org/aop/131	https://identifiers.org/aop/131	Aryl hydrocarbon receptor activation leading to uroporphyria
https://identifiers.org/aop.events/18	https://identifiers.org/aop.events/18	https://identifiers.org/aop/131	https://identifiers.org/aop/131	Aryl hydrocarbon receptor activation leading to uroporphyria
https://identifiers.org/aop.events/277	https://identifiers.org/aop.events/277	https://identifiers.org/aop/134	https://identifiers.org/aop/134	Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals
https://identifiers.org/aop.events/281	https://identifiers.org/aop.events/281	https://identifiers.org/aop/134	https://identifiers.org/aop/134	Sodium Iodide Symporter (NIS) Inhibition and Subsequent Adverse Neurodevelopmental Outcomes in Mammals
https://identifiers.org/aop.events/877	https://identifiers.org/aop.events/877	https://identifiers.org/aop/138	https://identifiers.org/aop/138	Organic anion transporter (OAT1) inhibition leading to renal failure and mortality
https://identifiers.org/aop.events/155	https://identifiers.org/aop.events/155	https://identifiers.org/aop/139	https://identifiers.org/aop/139	Alkylation of DNA leading to cancer 1
https://identifiers.org/aop.events/202	https://identifiers.org/aop.events/202	https://identifiers.org/aop/14	https://identifiers.org/aop/14	Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility
https://identifiers.org/aop.events/122	https://identifiers.org/aop.events/122	https://identifiers.org/aop/14	https://identifiers.org/aop/14	Glucocorticoid Receptor Activation Leading to Increased Disease Susceptibility
https://identifiers.org/aop.events/155	https://identifiers.org/aop.events/155	https://identifiers.org/aop/141	https://identifiers.org/aop/141	Alkylation of DNA leading to cancer 2
https://identifiers.org/aop.events/1493	https://identifiers.org/aop.events/1493	https://identifiers.org/aop/144	https://identifiers.org/aop/144	Endocytic lysosomal uptake leading to liver fibrosis
https://identifiers.org/aop.events/55	https://identifiers.org/aop.events/55	https://identifiers.org/aop/144	https://identifiers.org/aop/144	Endocytic lysosomal uptake leading to liver fibrosis
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/144	https://identifiers.org/aop/144	Endocytic lysosomal uptake leading to liver fibrosis
https://identifiers.org/aop.events/898	https://identifiers.org/aop.events/898	https://identifiers.org/aop/144	https://identifiers.org/aop/144	Endocytic lysosomal uptake leading to liver fibrosis
https://identifiers.org/aop.events/265	https://identifiers.org/aop.events/265	https://identifiers.org/aop/144	https://identifiers.org/aop/144	Endocytic lysosomal uptake leading to liver fibrosis
https://identifiers.org/aop.events/962	https://identifiers.org/aop.events/962	https://identifiers.org/aop/148	https://identifiers.org/aop/148	EGFR Activation Leading to Decreased Lung Function
https://identifiers.org/aop.events/941	https://identifiers.org/aop.events/941	https://identifiers.org/aop/148	https://identifiers.org/aop/148	EGFR Activation Leading to Decreased Lung Function
https://identifiers.org/aop.events/2117	https://identifiers.org/aop.events/2117	https://identifiers.org/aop/148	https://identifiers.org/aop/148	EGFR Activation Leading to Decreased Lung Function
https://identifiers.org/aop.events/973	https://identifiers.org/aop.events/973	https://identifiers.org/aop/149	https://identifiers.org/aop/149	Peptide Oxidation Leading to Hypertension
https://identifiers.org/aop.events/934	https://identifiers.org/aop.events/934	https://identifiers.org/aop/149	https://identifiers.org/aop/149	Peptide Oxidation Leading to Hypertension
https://identifiers.org/aop.events/209	https://identifiers.org/aop.events/209	https://identifiers.org/aop/149	https://identifiers.org/aop/149	Peptide Oxidation Leading to Hypertension
https://identifiers.org/aop.events/155	https://identifiers.org/aop.events/155	https://identifiers.org/aop/15	https://identifiers.org/aop/15	Alkylation of DNA in male pre-meiotic germ cells leading to heritable mutations
https://identifiers.org/aop.events/18	https://identifiers.org/aop.events/18	https://identifiers.org/aop/150	https://identifiers.org/aop/150	Aryl hydrocarbon receptor activation leading to early life stage mortality, via reduced VEGF
https://identifiers.org/aop.events/944	https://identifiers.org/aop.events/944	https://identifiers.org/aop/150	https://identifiers.org/aop/150	Aryl hydrocarbon receptor activation leading to early life stage mortality, via reduced VEGF
https://identifiers.org/aop.events/944	https://identifiers.org/aop.events/944	https://identifiers.org/aop/151	https://identifiers.org/aop/151	AhR activation leading to preeclampsia
https://identifiers.org/aop.events/18	https://identifiers.org/aop.events/18	https://identifiers.org/aop/151	https://identifiers.org/aop/151	AhR activation leading to preeclampsia
https://identifiers.org/aop.events/961	https://identifiers.org/aop.events/961	https://identifiers.org/aop/152	https://identifiers.org/aop/152	Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity 
https://identifiers.org/aop.events/960	https://identifiers.org/aop.events/960	https://identifiers.org/aop/152	https://identifiers.org/aop/152	Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity 
https://identifiers.org/aop.events/281	https://identifiers.org/aop.events/281	https://identifiers.org/aop/152	https://identifiers.org/aop/152	Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity 
https://identifiers.org/aop.events/958	https://identifiers.org/aop.events/958	https://identifiers.org/aop/152	https://identifiers.org/aop/152	Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity 
https://identifiers.org/aop.events/984	https://identifiers.org/aop.events/984	https://identifiers.org/aop/154	https://identifiers.org/aop/154	Inhibition of Calcineurin Activity Leading to Impaired T-Cell Dependent Antibody Response
https://identifiers.org/aop.events/981	https://identifiers.org/aop.events/981	https://identifiers.org/aop/154	https://identifiers.org/aop/154	Inhibition of Calcineurin Activity Leading to Impaired T-Cell Dependent Antibody Response
https://identifiers.org/aop.events/980	https://identifiers.org/aop.events/980	https://identifiers.org/aop/154	https://identifiers.org/aop/154	Inhibition of Calcineurin Activity Leading to Impaired T-Cell Dependent Antibody Response
https://identifiers.org/aop.events/1202	https://identifiers.org/aop.events/1202	https://identifiers.org/aop/154	https://identifiers.org/aop/154	Inhibition of Calcineurin Activity Leading to Impaired T-Cell Dependent Antibody Response
https://identifiers.org/aop.events/1003	https://identifiers.org/aop.events/1003	https://identifiers.org/aop/155	https://identifiers.org/aop/155	Deiodinase 2 inhibition leading to increased mortality via reduced posterior swim bladder inflation
https://identifiers.org/aop.events/1003	https://identifiers.org/aop.events/1003	https://identifiers.org/aop/156	https://identifiers.org/aop/156	Deiodinase 2 inhibition leading to increased mortality via reduced anterior swim bladder inflation
https://identifiers.org/aop.events/1003	https://identifiers.org/aop.events/1003	https://identifiers.org/aop/157	https://identifiers.org/aop/157	Deiodinase 1 inhibition leading to increased mortality via reduced posterior swim bladder inflation 
https://identifiers.org/aop.events/1003	https://identifiers.org/aop.events/1003	https://identifiers.org/aop/158	https://identifiers.org/aop/158	Deiodinase 1 inhibition leading to increased mortality via reduced anterior swim bladder inflation
https://identifiers.org/aop.events/277	https://identifiers.org/aop.events/277	https://identifiers.org/aop/159	https://identifiers.org/aop/159	Thyroperoxidase inhibition leading to increased mortality via reduced anterior swim bladder inflation
https://identifiers.org/aop.events/1003	https://identifiers.org/aop.events/1003	https://identifiers.org/aop/159	https://identifiers.org/aop/159	Thyroperoxidase inhibition leading to increased mortality via reduced anterior swim bladder inflation
https://identifiers.org/aop.events/281	https://identifiers.org/aop.events/281	https://identifiers.org/aop/159	https://identifiers.org/aop/159	Thyroperoxidase inhibition leading to increased mortality via reduced anterior swim bladder inflation
https://identifiers.org/aop.events/961	https://identifiers.org/aop.events/961	https://identifiers.org/aop/162	https://identifiers.org/aop/162	Enhanced hepatic clearance of thyroid hormones leading to thyroid follicular cell adenomas and carcinomas in the rat and mouse
https://identifiers.org/aop.events/281	https://identifiers.org/aop.events/281	https://identifiers.org/aop/162	https://identifiers.org/aop/162	Enhanced hepatic clearance of thyroid hormones leading to thyroid follicular cell adenomas and carcinomas in the rat and mouse
https://identifiers.org/aop.events/1046	https://identifiers.org/aop.events/1046	https://identifiers.org/aop/165	https://identifiers.org/aop/165	Antiestrogen activity leading to ovarian adenomas and granular cell tumors in the mouse
https://identifiers.org/aop.events/55	https://identifiers.org/aop.events/55	https://identifiers.org/aop/17	https://identifiers.org/aop/17	Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress during brain development leads to impairment of learning and memory
https://identifiers.org/aop.events/188	https://identifiers.org/aop.events/188	https://identifiers.org/aop/17	https://identifiers.org/aop/17	Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress during brain development leads to impairment of learning and memory
https://identifiers.org/aop.events/1492	https://identifiers.org/aop.events/1492	https://identifiers.org/aop/17	https://identifiers.org/aop/17	Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress during brain development leads to impairment of learning and memory
https://identifiers.org/aop.events/1538	https://identifiers.org/aop.events/1538	https://identifiers.org/aop/17	https://identifiers.org/aop/17	Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress during brain development leads to impairment of learning and memory
https://identifiers.org/aop.events/1392	https://identifiers.org/aop.events/1392	https://identifiers.org/aop/17	https://identifiers.org/aop/17	Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress during brain development leads to impairment of learning and memory
https://identifiers.org/aop.events/1488	https://identifiers.org/aop.events/1488	https://identifiers.org/aop/17	https://identifiers.org/aop/17	Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress during brain development leads to impairment of learning and memory
https://identifiers.org/aop.events/1493	https://identifiers.org/aop.events/1493	https://identifiers.org/aop/17	https://identifiers.org/aop/17	Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress during brain development leads to impairment of learning and memory
https://identifiers.org/aop.events/1495	https://identifiers.org/aop.events/1495	https://identifiers.org/aop/173	https://identifiers.org/aop/173	Substance interaction with the pulmonary resident cell membrane components leading to pulmonary fibrosis
https://identifiers.org/aop.events/1499	https://identifiers.org/aop.events/1499	https://identifiers.org/aop/173	https://identifiers.org/aop/173	Substance interaction with the pulmonary resident cell membrane components leading to pulmonary fibrosis
https://identifiers.org/aop.events/1458	https://identifiers.org/aop.events/1458	https://identifiers.org/aop/173	https://identifiers.org/aop/173	Substance interaction with the pulmonary resident cell membrane components leading to pulmonary fibrosis
https://identifiers.org/aop.events/1496	https://identifiers.org/aop.events/1496	https://identifiers.org/aop/173	https://identifiers.org/aop/173	Substance interaction with the pulmonary resident cell membrane components leading to pulmonary fibrosis
https://identifiers.org/aop.events/1500	https://identifiers.org/aop.events/1500	https://identifiers.org/aop/173	https://identifiers.org/aop/173	Substance interaction with the pulmonary resident cell membrane components leading to pulmonary fibrosis
https://identifiers.org/aop.events/281	https://identifiers.org/aop.events/281	https://identifiers.org/aop/175	https://identifiers.org/aop/175	Thyroperoxidase inhibition leading to altered amphibian metamorphosis
https://identifiers.org/aop.events/277	https://identifiers.org/aop.events/277	https://identifiers.org/aop/175	https://identifiers.org/aop/175	Thyroperoxidase inhibition leading to altered amphibian metamorphosis
https://identifiers.org/aop.events/281	https://identifiers.org/aop.events/281	https://identifiers.org/aop/176	https://identifiers.org/aop/176	Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis
https://identifiers.org/aop.events/277	https://identifiers.org/aop.events/277	https://identifiers.org/aop/176	https://identifiers.org/aop/176	Sodium Iodide Symporter (NIS) Inhibition leading to altered amphibian metamorphosis
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/178	https://identifiers.org/aop/178	Nicotinic acetylcholine receptor activation contributes to mitochondrial dysfunction and leads to colony loss/failure
https://identifiers.org/aop.events/277	https://identifiers.org/aop.events/277	https://identifiers.org/aop/188	https://identifiers.org/aop/188	Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis
https://identifiers.org/aop.events/281	https://identifiers.org/aop.events/281	https://identifiers.org/aop/188	https://identifiers.org/aop/188	Iodotyrosine deiodinase (IYD) inhibition leading to altered amphibian metamorphosis
https://identifiers.org/aop.events/1003	https://identifiers.org/aop.events/1003	https://identifiers.org/aop/189	https://identifiers.org/aop/189	Type I iodothyronine deiodinase (DIO1) inhibition leading to altered amphibian metamorphosis
https://identifiers.org/aop.events/277	https://identifiers.org/aop.events/277	https://identifiers.org/aop/192	https://identifiers.org/aop/192	Pendrin inhibition leading to altered amphibian metamorphosis
https://identifiers.org/aop.events/281	https://identifiers.org/aop.events/281	https://identifiers.org/aop/192	https://identifiers.org/aop/192	Pendrin inhibition leading to altered amphibian metamorphosis
https://identifiers.org/aop.events/277	https://identifiers.org/aop.events/277	https://identifiers.org/aop/193	https://identifiers.org/aop/193	Dual oxidase (DUOX) inhibition leading to altered amphibian metamorphosis
https://identifiers.org/aop.events/281	https://identifiers.org/aop.events/281	https://identifiers.org/aop/193	https://identifiers.org/aop/193	Dual oxidase (DUOX) inhibition leading to altered amphibian metamorphosis
https://identifiers.org/aop.events/961	https://identifiers.org/aop.events/961	https://identifiers.org/aop/194	https://identifiers.org/aop/194	Hepatic nuclear receptor activation leading to altered amphibian metamorphosis
https://identifiers.org/aop.events/281	https://identifiers.org/aop.events/281	https://identifiers.org/aop/194	https://identifiers.org/aop/194	Hepatic nuclear receptor activation leading to altered amphibian metamorphosis
https://identifiers.org/aop.events/619	https://identifiers.org/aop.events/619	https://identifiers.org/aop/195	https://identifiers.org/aop/195	5-hydroxytryptamine transporter (5-HTT) inhibition leading to population increase
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/200	https://identifiers.org/aop/200	Estrogen receptor activation leading to breast cancer  
https://identifiers.org/aop.events/1193	https://identifiers.org/aop.events/1193	https://identifiers.org/aop/200	https://identifiers.org/aop/200	Estrogen receptor activation leading to breast cancer  
https://identifiers.org/aop.events/1252	https://identifiers.org/aop.events/1252	https://identifiers.org/aop/202	https://identifiers.org/aop/202	 Inhibitor binding to topoisomerase II leading to infant leukaemia
https://identifiers.org/aop.events/1254	https://identifiers.org/aop.events/1254	https://identifiers.org/aop/202	https://identifiers.org/aop/202	 Inhibitor binding to topoisomerase II leading to infant leukaemia
https://identifiers.org/aop.events/1253	https://identifiers.org/aop.events/1253	https://identifiers.org/aop/202	https://identifiers.org/aop/202	 Inhibitor binding to topoisomerase II leading to infant leukaemia
https://identifiers.org/aop.events/619	https://identifiers.org/aop.events/619	https://identifiers.org/aop/203	https://identifiers.org/aop/203	5-hydroxytryptamine transporter inhibition leading to decreased reproductive success and population decline
https://identifiers.org/aop.events/619	https://identifiers.org/aop.events/619	https://identifiers.org/aop/204	https://identifiers.org/aop/204	5-hydroxytryptamine transporter inhibition leading to increased reproductive success and population increase
https://identifiers.org/aop.events/1262	https://identifiers.org/aop.events/1262	https://identifiers.org/aop/205	https://identifiers.org/aop/205	AOP from chemical insult to cell death
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/205	https://identifiers.org/aop/205	AOP from chemical insult to cell death
https://identifiers.org/aop.events/1457	https://identifiers.org/aop.events/1457	https://identifiers.org/aop/206	https://identifiers.org/aop/206	Peroxisome proliferator-activated receptors γ inactivation leading to lung fibrosis
https://identifiers.org/aop.events/149	https://identifiers.org/aop.events/149	https://identifiers.org/aop/206	https://identifiers.org/aop/206	Peroxisome proliferator-activated receptors γ inactivation leading to lung fibrosis
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/207	https://identifiers.org/aop/207	NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans
https://identifiers.org/aop.events/1262	https://identifiers.org/aop.events/1262	https://identifiers.org/aop/207	https://identifiers.org/aop/207	NADPH oxidase and P38 MAPK activation leading to reproductive failure in Caenorhabditis elegans
https://identifiers.org/aop.events/209	https://identifiers.org/aop.events/209	https://identifiers.org/aop/210	https://identifiers.org/aop/210	Activation of c-Jun N-terminal kinase (JNK) and Forkhead box O (FOXO) and reduction of WNT pathways leading to reproductive failure: Integrated multi-OMICS approach for AOP building
https://identifiers.org/aop.events/1503	https://identifiers.org/aop.events/1503	https://identifiers.org/aop/212	https://identifiers.org/aop/212	Histone deacetylase inhibition leading to testicular atrophy
https://identifiers.org/aop.events/1262	https://identifiers.org/aop.events/1262	https://identifiers.org/aop/212	https://identifiers.org/aop/212	Histone deacetylase inhibition leading to testicular atrophy
https://identifiers.org/aop.events/1515	https://identifiers.org/aop.events/1515	https://identifiers.org/aop/212	https://identifiers.org/aop/212	Histone deacetylase inhibition leading to testicular atrophy
https://identifiers.org/aop.events/1502	https://identifiers.org/aop.events/1502	https://identifiers.org/aop/212	https://identifiers.org/aop/212	Histone deacetylase inhibition leading to testicular atrophy
https://identifiers.org/aop.events/122	https://identifiers.org/aop.events/122	https://identifiers.org/aop/214	https://identifiers.org/aop/214	Network of SSRIs (selective serotonin reuptake inhibitors)
https://identifiers.org/aop.events/1339	https://identifiers.org/aop.events/1339	https://identifiers.org/aop/214	https://identifiers.org/aop/214	Network of SSRIs (selective serotonin reuptake inhibitors)
https://identifiers.org/aop.events/1387	https://identifiers.org/aop.events/1387	https://identifiers.org/aop/218	https://identifiers.org/aop/218	Inhibition of CYP7B activity leads to decreased reproductive success via decreased locomotor activity
https://identifiers.org/aop.events/1387	https://identifiers.org/aop.events/1387	https://identifiers.org/aop/219	https://identifiers.org/aop/219	Inhibition of CYP7B activity leads to decreased reproductive success via decreased sexual behavior
https://identifiers.org/aop.events/1394	https://identifiers.org/aop.events/1394	https://identifiers.org/aop/220	https://identifiers.org/aop/220	Cyp2E1 Activation Leading to Liver Cancer
https://identifiers.org/aop.events/1391	https://identifiers.org/aop.events/1391	https://identifiers.org/aop/220	https://identifiers.org/aop/220	Cyp2E1 Activation Leading to Liver Cancer
https://identifiers.org/aop.events/1392	https://identifiers.org/aop.events/1392	https://identifiers.org/aop/220	https://identifiers.org/aop/220	Cyp2E1 Activation Leading to Liver Cancer
https://identifiers.org/aop.events/1339	https://identifiers.org/aop.events/1339	https://identifiers.org/aop/226	https://identifiers.org/aop/226	SSRI (Selective serotonin reuptake inhibitor) to hypertension
https://identifiers.org/aop.events/1439	https://identifiers.org/aop.events/1439	https://identifiers.org/aop/237	https://identifiers.org/aop/237	Substance interaction with lung resident cell membrane components leading to atherosclerosis
https://identifiers.org/aop.events/1495	https://identifiers.org/aop.events/1495	https://identifiers.org/aop/237	https://identifiers.org/aop/237	Substance interaction with lung resident cell membrane components leading to atherosclerosis
https://identifiers.org/aop.events/1438	https://identifiers.org/aop.events/1438	https://identifiers.org/aop/237	https://identifiers.org/aop/237	Substance interaction with lung resident cell membrane components leading to atherosclerosis
https://identifiers.org/aop.events/1496	https://identifiers.org/aop.events/1496	https://identifiers.org/aop/237	https://identifiers.org/aop/237	Substance interaction with lung resident cell membrane components leading to atherosclerosis
https://identifiers.org/aop.events/1457	https://identifiers.org/aop.events/1457	https://identifiers.org/aop/241	https://identifiers.org/aop/241	Latent Transforming Growth Factor beta1 activation leads to pulmonary fibrosis
https://identifiers.org/aop.events/1458	https://identifiers.org/aop.events/1458	https://identifiers.org/aop/241	https://identifiers.org/aop/241	Latent Transforming Growth Factor beta1 activation leads to pulmonary fibrosis
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/256	https://identifiers.org/aop/256	Inhibition of mitochondrial DNA polymerase gamma leading to kidney toxicity
https://identifiers.org/aop.events/814	https://identifiers.org/aop.events/814	https://identifiers.org/aop/256	https://identifiers.org/aop/256	Inhibition of mitochondrial DNA polymerase gamma leading to kidney toxicity
https://identifiers.org/aop.events/709	https://identifiers.org/aop.events/709	https://identifiers.org/aop/256	https://identifiers.org/aop/256	Inhibition of mitochondrial DNA polymerase gamma leading to kidney toxicity
https://identifiers.org/aop.events/898	https://identifiers.org/aop.events/898	https://identifiers.org/aop/257	https://identifiers.org/aop/257	Receptor mediated endocytosis and lysosomal overload leading to kidney toxicity
https://identifiers.org/aop.events/709	https://identifiers.org/aop.events/709	https://identifiers.org/aop/257	https://identifiers.org/aop/257	Receptor mediated endocytosis and lysosomal overload leading to kidney toxicity
https://identifiers.org/aop.events/814	https://identifiers.org/aop.events/814	https://identifiers.org/aop/257	https://identifiers.org/aop/257	Receptor mediated endocytosis and lysosomal overload leading to kidney toxicity
https://identifiers.org/aop.events/709	https://identifiers.org/aop.events/709	https://identifiers.org/aop/258	https://identifiers.org/aop/258	Renal protein alkylation leading to kidney toxicity
https://identifiers.org/aop.events/814	https://identifiers.org/aop.events/814	https://identifiers.org/aop/258	https://identifiers.org/aop/258	Renal protein alkylation leading to kidney toxicity
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/258	https://identifiers.org/aop/258	Renal protein alkylation leading to kidney toxicity
https://identifiers.org/aop.events/1512	https://identifiers.org/aop.events/1512	https://identifiers.org/aop/260	https://identifiers.org/aop/260	CYP2E1 activation and formation of protein adducts leading to neurodegeneration
https://identifiers.org/aop.events/1513	https://identifiers.org/aop.events/1513	https://identifiers.org/aop/260	https://identifiers.org/aop/260	CYP2E1 activation and formation of protein adducts leading to neurodegeneration
https://identifiers.org/aop.events/1508	https://identifiers.org/aop.events/1508	https://identifiers.org/aop/260	https://identifiers.org/aop/260	CYP2E1 activation and formation of protein adducts leading to neurodegeneration
https://identifiers.org/aop.events/55	https://identifiers.org/aop.events/55	https://identifiers.org/aop/264	https://identifiers.org/aop/264	Uncoupling of oxidative phosphorylation leading to growth inhibition via ATP depletion associated cell death
https://identifiers.org/aop.events/55	https://identifiers.org/aop.events/55	https://identifiers.org/aop/265	https://identifiers.org/aop/265	Uncoupling of oxidative phosphorylation leading to growth inhibition via increased cytosolic calcium
https://identifiers.org/aop.events/55	https://identifiers.org/aop.events/55	https://identifiers.org/aop/266	https://identifiers.org/aop/266	Uncoupling of oxidative phosphorylation leading to growth inhibition via decreased Na-K ATPase activity
https://identifiers.org/aop.events/55	https://identifiers.org/aop.events/55	https://identifiers.org/aop/268	https://identifiers.org/aop/268	Uncoupling of oxidative phosphorylation leading to growth inhibition via mitochondrial swelling
https://identifiers.org/aop.events/149	https://identifiers.org/aop.events/149	https://identifiers.org/aop/27	https://identifiers.org/aop/27	Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11)
https://identifiers.org/aop.events/209	https://identifiers.org/aop.events/209	https://identifiers.org/aop/27	https://identifiers.org/aop/27	Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11)
https://identifiers.org/aop.events/87	https://identifiers.org/aop.events/87	https://identifiers.org/aop/27	https://identifiers.org/aop/27	Cholestatic Liver Injury induced by Inhibition of the Bile Salt Export Pump (ABCB11)
https://identifiers.org/aop.events/277	https://identifiers.org/aop.events/277	https://identifiers.org/aop/271	https://identifiers.org/aop/271	Inhibition of thyroid peroxidase leading to impaired fertility in fish
https://identifiers.org/aop.events/155	https://identifiers.org/aop.events/155	https://identifiers.org/aop/272	https://identifiers.org/aop/272	Deposition of energy leading to lung cancer
https://identifiers.org/aop.events/55	https://identifiers.org/aop.events/55	https://identifiers.org/aop/273	https://identifiers.org/aop/273	Mitochondrial complex inhibition leading to liver injury
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/273	https://identifiers.org/aop/273	Mitochondrial complex inhibition leading to liver injury
https://identifiers.org/aop.events/888	https://identifiers.org/aop.events/888	https://identifiers.org/aop/273	https://identifiers.org/aop/273	Mitochondrial complex inhibition leading to liver injury
https://identifiers.org/aop.events/1502	https://identifiers.org/aop.events/1502	https://identifiers.org/aop/274	https://identifiers.org/aop/274	Histone deacetylase inhibition leads to impeded craniofacial development
https://identifiers.org/aop.events/1557	https://identifiers.org/aop.events/1557	https://identifiers.org/aop/274	https://identifiers.org/aop/274	Histone deacetylase inhibition leads to impeded craniofacial development
https://identifiers.org/aop.events/1502	https://identifiers.org/aop.events/1502	https://identifiers.org/aop/275	https://identifiers.org/aop/275	Histone deacetylase inhibition leads to neural tube defects
https://identifiers.org/aop.events/1503	https://identifiers.org/aop.events/1503	https://identifiers.org/aop/275	https://identifiers.org/aop/275	Histone deacetylase inhibition leads to neural tube defects
https://identifiers.org/aop.events/888	https://identifiers.org/aop.events/888	https://identifiers.org/aop/276	https://identifiers.org/aop/276	Inhibition of complex I of the electron transport chain leading to chemical induced Fanconi syndrome
https://identifiers.org/aop.events/202	https://identifiers.org/aop.events/202	https://identifiers.org/aop/277	https://identifiers.org/aop/277	Impaired IL-1R1 signaling leading to Impaired T-Cell Dependent Antibody Response
https://identifiers.org/aop.events/1700	https://identifiers.org/aop.events/1700	https://identifiers.org/aop/277	https://identifiers.org/aop/277	Impaired IL-1R1 signaling leading to Impaired T-Cell Dependent Antibody Response
https://identifiers.org/aop.events/984	https://identifiers.org/aop.events/984	https://identifiers.org/aop/277	https://identifiers.org/aop/277	Impaired IL-1R1 signaling leading to Impaired T-Cell Dependent Antibody Response
https://identifiers.org/aop.events/55	https://identifiers.org/aop.events/55	https://identifiers.org/aop/278	https://identifiers.org/aop/278	IKK complex inhibition leading to liver injury
https://identifiers.org/aop.events/202	https://identifiers.org/aop.events/202	https://identifiers.org/aop/278	https://identifiers.org/aop/278	IKK complex inhibition leading to liver injury
https://identifiers.org/aop.events/149	https://identifiers.org/aop.events/149	https://identifiers.org/aop/280	https://identifiers.org/aop/280	α-diketone-induced bronchiolitis obliterans
https://identifiers.org/aop.events/1457	https://identifiers.org/aop.events/1457	https://identifiers.org/aop/280	https://identifiers.org/aop/280	α-diketone-induced bronchiolitis obliterans
https://identifiers.org/aop.events/1602	https://identifiers.org/aop.events/1602	https://identifiers.org/aop/281	https://identifiers.org/aop/281	Acetylcholinesterase Inhibition Leading to Neurodegeneration
https://identifiers.org/aop.events/352	https://identifiers.org/aop.events/352	https://identifiers.org/aop/281	https://identifiers.org/aop/281	Acetylcholinesterase Inhibition Leading to Neurodegeneration
https://identifiers.org/aop.events/55	https://identifiers.org/aop.events/55	https://identifiers.org/aop/281	https://identifiers.org/aop/281	Acetylcholinesterase Inhibition Leading to Neurodegeneration
https://identifiers.org/aop.events/1392	https://identifiers.org/aop.events/1392	https://identifiers.org/aop/284	https://identifiers.org/aop/284	Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress leads to chronic kidney disease
https://identifiers.org/aop.events/1538	https://identifiers.org/aop.events/1538	https://identifiers.org/aop/284	https://identifiers.org/aop/284	Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress leads to chronic kidney disease
https://identifiers.org/aop.events/1262	https://identifiers.org/aop.events/1262	https://identifiers.org/aop/285	https://identifiers.org/aop/285	Inhibition of N-linked glycosylation leads to liver injury
https://identifiers.org/aop.events/1512	https://identifiers.org/aop.events/1512	https://identifiers.org/aop/285	https://identifiers.org/aop/285	Inhibition of N-linked glycosylation leads to liver injury
https://identifiers.org/aop.events/1825	https://identifiers.org/aop.events/1825	https://identifiers.org/aop/287	https://identifiers.org/aop/287	Mitochondrial complex III antagonism leading to growth inhibition (2)
https://identifiers.org/aop.events/1825	https://identifiers.org/aop.events/1825	https://identifiers.org/aop/291	https://identifiers.org/aop/291	Mitochondrial ATP synthase antagonism leading to growth inhibition (2)
https://identifiers.org/aop.events/1493	https://identifiers.org/aop.events/1493	https://identifiers.org/aop/293	https://identifiers.org/aop/293	Increased DNA damage leading to increased risk of breast cancer
https://identifiers.org/aop.events/1632	https://identifiers.org/aop.events/1632	https://identifiers.org/aop/293	https://identifiers.org/aop/293	Increased DNA damage leading to increased risk of breast cancer
https://identifiers.org/aop.events/1193	https://identifiers.org/aop.events/1193	https://identifiers.org/aop/293	https://identifiers.org/aop/293	Increased DNA damage leading to increased risk of breast cancer
https://identifiers.org/aop.events/1492	https://identifiers.org/aop.events/1492	https://identifiers.org/aop/293	https://identifiers.org/aop/293	Increased DNA damage leading to increased risk of breast cancer
https://identifiers.org/aop.events/1492	https://identifiers.org/aop.events/1492	https://identifiers.org/aop/294	https://identifiers.org/aop/294	Increased reactive oxygen and nitrogen species (RONS) leading to increased risk of breast cancer
https://identifiers.org/aop.events/1632	https://identifiers.org/aop.events/1632	https://identifiers.org/aop/294	https://identifiers.org/aop/294	Increased reactive oxygen and nitrogen species (RONS) leading to increased risk of breast cancer
https://identifiers.org/aop.events/1193	https://identifiers.org/aop.events/1193	https://identifiers.org/aop/294	https://identifiers.org/aop/294	Increased reactive oxygen and nitrogen species (RONS) leading to increased risk of breast cancer
https://identifiers.org/aop.events/1493	https://identifiers.org/aop.events/1493	https://identifiers.org/aop/294	https://identifiers.org/aop/294	Increased reactive oxygen and nitrogen species (RONS) leading to increased risk of breast cancer
https://identifiers.org/aop.events/1634	https://identifiers.org/aop.events/1634	https://identifiers.org/aop/296	https://identifiers.org/aop/296	Oxidative DNA damage leading to chromosomal aberrations and mutations
https://identifiers.org/aop.events/155	https://identifiers.org/aop.events/155	https://identifiers.org/aop/296	https://identifiers.org/aop/296	Oxidative DNA damage leading to chromosomal aberrations and mutations
https://identifiers.org/aop.events/1457	https://identifiers.org/aop.events/1457	https://identifiers.org/aop/298	https://identifiers.org/aop/298	Increases in cellular reactive oxygen species and chronic reactive oxygen species leading to human treatment-resistant gastric cancer
https://identifiers.org/aop.events/1755	https://identifiers.org/aop.events/1755	https://identifiers.org/aop/298	https://identifiers.org/aop/298	Increases in cellular reactive oxygen species and chronic reactive oxygen species leading to human treatment-resistant gastric cancer
https://identifiers.org/aop.events/1634	https://identifiers.org/aop.events/1634	https://identifiers.org/aop/299	https://identifiers.org/aop/299	Deposition of energy leading to population decline via DNA oxidation and follicular atresia
https://identifiers.org/aop.events/888	https://identifiers.org/aop.events/888	https://identifiers.org/aop/3	https://identifiers.org/aop/3	Inhibition of the mitochondrial complex I of nigro-striatal neurons leads to parkinsonian motor deficits
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/3	https://identifiers.org/aop/3	Inhibition of the mitochondrial complex I of nigro-striatal neurons leads to parkinsonian motor deficits
https://identifiers.org/aop.events/188	https://identifiers.org/aop.events/188	https://identifiers.org/aop/3	https://identifiers.org/aop/3	Inhibition of the mitochondrial complex I of nigro-striatal neurons leads to parkinsonian motor deficits
https://identifiers.org/aop.events/87	https://identifiers.org/aop.events/87	https://identifiers.org/aop/303	https://identifiers.org/aop/303	Frustrated phagocytosis-induced lung cancer
https://identifiers.org/aop.events/944	https://identifiers.org/aop.events/944	https://identifiers.org/aop/310	https://identifiers.org/aop/310	Embryonic Activation of the AHR leading to Reproductive failure, via epigenetic down-regulation of GnRHR
https://identifiers.org/aop.events/18	https://identifiers.org/aop.events/18	https://identifiers.org/aop/310	https://identifiers.org/aop/310	Embryonic Activation of the AHR leading to Reproductive failure, via epigenetic down-regulation of GnRHR
https://identifiers.org/aop.events/1634	https://identifiers.org/aop.events/1634	https://identifiers.org/aop/311	https://identifiers.org/aop/311	Deposition of energy leading to population decline via DNA oxidation and oocyte apoptosis
https://identifiers.org/aop.events/1822	https://identifiers.org/aop.events/1822	https://identifiers.org/aop/313	https://identifiers.org/aop/313	Stimulation of TLR7/8 in dendric cells leading to Psoriatic skin disease
https://identifiers.org/aop.events/1709	https://identifiers.org/aop.events/1709	https://identifiers.org/aop/313	https://identifiers.org/aop/313	Stimulation of TLR7/8 in dendric cells leading to Psoriatic skin disease
https://identifiers.org/aop.events/1708	https://identifiers.org/aop.events/1708	https://identifiers.org/aop/313	https://identifiers.org/aop/313	Stimulation of TLR7/8 in dendric cells leading to Psoriatic skin disease
https://identifiers.org/aop.events/1706	https://identifiers.org/aop.events/1706	https://identifiers.org/aop/313	https://identifiers.org/aop/313	Stimulation of TLR7/8 in dendric cells leading to Psoriatic skin disease
https://identifiers.org/aop.events/1712	https://identifiers.org/aop.events/1712	https://identifiers.org/aop/314	https://identifiers.org/aop/314	Binding to estrogen receptor (ER)-α in immune cells leading to exacerbation of systemic lupus erythematosus (SLE)
https://identifiers.org/aop.events/1711	https://identifiers.org/aop.events/1711	https://identifiers.org/aop/314	https://identifiers.org/aop/314	Binding to estrogen receptor (ER)-α in immune cells leading to exacerbation of systemic lupus erythematosus (SLE)
https://identifiers.org/aop.events/1713	https://identifiers.org/aop.events/1713	https://identifiers.org/aop/314	https://identifiers.org/aop/314	Binding to estrogen receptor (ER)-α in immune cells leading to exacerbation of systemic lupus erythematosus (SLE)
https://identifiers.org/aop.events/1710	https://identifiers.org/aop.events/1710	https://identifiers.org/aop/314	https://identifiers.org/aop/314	Binding to estrogen receptor (ER)-α in immune cells leading to exacerbation of systemic lupus erythematosus (SLE)
https://identifiers.org/aop.events/1718	https://identifiers.org/aop.events/1718	https://identifiers.org/aop/315	https://identifiers.org/aop/315	Inhibition of JAK3 leading to impairment of T-Cell Dependent Antibody Response
https://identifiers.org/aop.events/1719	https://identifiers.org/aop.events/1719	https://identifiers.org/aop/315	https://identifiers.org/aop/315	Inhibition of JAK3 leading to impairment of T-Cell Dependent Antibody Response
https://identifiers.org/aop.events/1716	https://identifiers.org/aop.events/1716	https://identifiers.org/aop/315	https://identifiers.org/aop/315	Inhibition of JAK3 leading to impairment of T-Cell Dependent Antibody Response
https://identifiers.org/aop.events/1717	https://identifiers.org/aop.events/1717	https://identifiers.org/aop/315	https://identifiers.org/aop/315	Inhibition of JAK3 leading to impairment of T-Cell Dependent Antibody Response
https://identifiers.org/aop.events/1715	https://identifiers.org/aop.events/1715	https://identifiers.org/aop/315	https://identifiers.org/aop/315	Inhibition of JAK3 leading to impairment of T-Cell Dependent Antibody Response
https://identifiers.org/aop.events/1721	https://identifiers.org/aop.events/1721	https://identifiers.org/aop/316	https://identifiers.org/aop/316	Trypsin inhibition leading to pancreatic acinar cell tumors
https://identifiers.org/aop.events/1724	https://identifiers.org/aop.events/1724	https://identifiers.org/aop/316	https://identifiers.org/aop/316	Trypsin inhibition leading to pancreatic acinar cell tumors
https://identifiers.org/aop.events/1722	https://identifiers.org/aop.events/1722	https://identifiers.org/aop/316	https://identifiers.org/aop/316	Trypsin inhibition leading to pancreatic acinar cell tumors
https://identifiers.org/aop.events/1723	https://identifiers.org/aop.events/1723	https://identifiers.org/aop/316	https://identifiers.org/aop/316	Trypsin inhibition leading to pancreatic acinar cell tumors
https://identifiers.org/aop.events/1725	https://identifiers.org/aop.events/1725	https://identifiers.org/aop/316	https://identifiers.org/aop/316	Trypsin inhibition leading to pancreatic acinar cell tumors
https://identifiers.org/aop.events/1720	https://identifiers.org/aop.events/1720	https://identifiers.org/aop/316	https://identifiers.org/aop/316	Trypsin inhibition leading to pancreatic acinar cell tumors
https://identifiers.org/aop.events/291	https://identifiers.org/aop.events/291	https://identifiers.org/aop/318	https://identifiers.org/aop/318	Glucocorticoid Receptor activation leading to hepatic steatosis
https://identifiers.org/aop.events/122	https://identifiers.org/aop.events/122	https://identifiers.org/aop/318	https://identifiers.org/aop/318	Glucocorticoid Receptor activation leading to hepatic steatosis
https://identifiers.org/aop.events/1496	https://identifiers.org/aop.events/1496	https://identifiers.org/aop/319	https://identifiers.org/aop/319	Binding to ACE2 leading to lung fibrosis
https://identifiers.org/aop.events/1854	https://identifiers.org/aop.events/1854	https://identifiers.org/aop/319	https://identifiers.org/aop/319	Binding to ACE2 leading to lung fibrosis
https://identifiers.org/aop.events/1738	https://identifiers.org/aop.events/1738	https://identifiers.org/aop/320	https://identifiers.org/aop/320	Binding of SARS-CoV-2 to ACE2 receptor leading to acute respiratory distress associated mortality
https://identifiers.org/aop.events/1848	https://identifiers.org/aop.events/1848	https://identifiers.org/aop/320	https://identifiers.org/aop/320	Binding of SARS-CoV-2 to ACE2 receptor leading to acute respiratory distress associated mortality
https://identifiers.org/aop.events/1847	https://identifiers.org/aop.events/1847	https://identifiers.org/aop/320	https://identifiers.org/aop/320	Binding of SARS-CoV-2 to ACE2 receptor leading to acute respiratory distress associated mortality
https://identifiers.org/aop.events/1496	https://identifiers.org/aop.events/1496	https://identifiers.org/aop/320	https://identifiers.org/aop/320	Binding of SARS-CoV-2 to ACE2 receptor leading to acute respiratory distress associated mortality
https://identifiers.org/aop.events/1901	https://identifiers.org/aop.events/1901	https://identifiers.org/aop/320	https://identifiers.org/aop/320	Binding of SARS-CoV-2 to ACE2 receptor leading to acute respiratory distress associated mortality
https://identifiers.org/aop.events/155	https://identifiers.org/aop.events/155	https://identifiers.org/aop/322	https://identifiers.org/aop/322	Alkylation of DNA leading to reduced sperm count
https://identifiers.org/aop.events/1756	https://identifiers.org/aop.events/1756	https://identifiers.org/aop/323	https://identifiers.org/aop/323	PPARalpha Agonism Leading to Decreased Viable Offspring via Decreased 11-Ketotestosterone
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/324	https://identifiers.org/aop/324	Thermal stress leading to population decline (1)
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/325	https://identifiers.org/aop/325	Thermal stress leading to population decline (2)
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/326	https://identifiers.org/aop/326	Thermal stress leading to population decline (3)
https://identifiers.org/aop.events/122	https://identifiers.org/aop.events/122	https://identifiers.org/aop/334	https://identifiers.org/aop/334	Glucocorticoid Receptor Agonism Leading to Impaired Fin Regeneration
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/335	https://identifiers.org/aop/335	AOP for urothelial carcinogenesis due to chemical cytotoxicity by mitochondrial impairment 
https://identifiers.org/aop.events/89	https://identifiers.org/aop.events/89	https://identifiers.org/aop/34	https://identifiers.org/aop/34	LXR activation leading to hepatic steatosis
https://identifiers.org/aop.events/66	https://identifiers.org/aop.events/66	https://identifiers.org/aop/34	https://identifiers.org/aop/34	LXR activation leading to hepatic steatosis
https://identifiers.org/aop.events/167	https://identifiers.org/aop.events/167	https://identifiers.org/aop/34	https://identifiers.org/aop/34	LXR activation leading to hepatic steatosis
https://identifiers.org/aop.events/258	https://identifiers.org/aop.events/258	https://identifiers.org/aop/34	https://identifiers.org/aop/34	LXR activation leading to hepatic steatosis
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/34	https://identifiers.org/aop/34	LXR activation leading to hepatic steatosis
https://identifiers.org/aop.events/116	https://identifiers.org/aop.events/116	https://identifiers.org/aop/34	https://identifiers.org/aop/34	LXR activation leading to hepatic steatosis
https://identifiers.org/aop.events/264	https://identifiers.org/aop.events/264	https://identifiers.org/aop/34	https://identifiers.org/aop/34	LXR activation leading to hepatic steatosis
https://identifiers.org/aop.events/291	https://identifiers.org/aop.events/291	https://identifiers.org/aop/34	https://identifiers.org/aop/34	LXR activation leading to hepatic steatosis
https://identifiers.org/aop.events/1457	https://identifiers.org/aop.events/1457	https://identifiers.org/aop/347	https://identifiers.org/aop/347	Toll-like receptor 4 activation and peroxisome proliferator-activated receptor gamma inactivation leading to pulmonary fibrosis
https://identifiers.org/aop.events/1458	https://identifiers.org/aop.events/1458	https://identifiers.org/aop/347	https://identifiers.org/aop/347	Toll-like receptor 4 activation and peroxisome proliferator-activated receptor gamma inactivation leading to pulmonary fibrosis
https://identifiers.org/aop.events/1756	https://identifiers.org/aop.events/1756	https://identifiers.org/aop/348	https://identifiers.org/aop/348	Inhibition of 11β-Hydroxysteroid Dehydrogenase leading to decreased population trajectory 
https://identifiers.org/aop.events/1756	https://identifiers.org/aop.events/1756	https://identifiers.org/aop/349	https://identifiers.org/aop/349	Inhibition of 11β-hydroxylase leading to decresed population trajectory 
https://identifiers.org/aop.events/233	https://identifiers.org/aop.events/233	https://identifiers.org/aop/36	https://identifiers.org/aop/36	Peroxisomal Fatty Acid Beta-Oxidation Inhibition Leading to Steatosis
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/362	https://identifiers.org/aop/362	Immune mediated hepatitis
https://identifiers.org/aop.events/281	https://identifiers.org/aop.events/281	https://identifiers.org/aop/363	https://identifiers.org/aop/363	Thyroperoxidase inhibition leading to altered visual function via altered retinal layer structure
https://identifiers.org/aop.events/277	https://identifiers.org/aop.events/277	https://identifiers.org/aop/363	https://identifiers.org/aop/363	Thyroperoxidase inhibition leading to altered visual function via altered retinal layer structure
https://identifiers.org/aop.events/1003	https://identifiers.org/aop.events/1003	https://identifiers.org/aop/363	https://identifiers.org/aop/363	Thyroperoxidase inhibition leading to altered visual function via altered retinal layer structure
https://identifiers.org/aop.events/281	https://identifiers.org/aop.events/281	https://identifiers.org/aop/364	https://identifiers.org/aop/364	Thyroperoxidase inhibition leading to altered visual function via decreased eye size
https://identifiers.org/aop.events/277	https://identifiers.org/aop.events/277	https://identifiers.org/aop/364	https://identifiers.org/aop/364	Thyroperoxidase inhibition leading to altered visual function via decreased eye size
https://identifiers.org/aop.events/1003	https://identifiers.org/aop.events/1003	https://identifiers.org/aop/364	https://identifiers.org/aop/364	Thyroperoxidase inhibition leading to altered visual function via decreased eye size
https://identifiers.org/aop.events/281	https://identifiers.org/aop.events/281	https://identifiers.org/aop/365	https://identifiers.org/aop/365	Thyroperoxidase inhibition leading to altered visual function via altered photoreceptor patterning
https://identifiers.org/aop.events/277	https://identifiers.org/aop.events/277	https://identifiers.org/aop/365	https://identifiers.org/aop/365	Thyroperoxidase inhibition leading to altered visual function via altered photoreceptor patterning
https://identifiers.org/aop.events/1003	https://identifiers.org/aop.events/1003	https://identifiers.org/aop/365	https://identifiers.org/aop/365	Thyroperoxidase inhibition leading to altered visual function via altered photoreceptor patterning
https://identifiers.org/aop.events/281	https://identifiers.org/aop.events/281	https://identifiers.org/aop/366	https://identifiers.org/aop/366	Competitive binding to thyroid hormone carrier protein transthyretin (TTR) leading to altered amphibian metamorphosis 
https://identifiers.org/aop.events/961	https://identifiers.org/aop.events/961	https://identifiers.org/aop/366	https://identifiers.org/aop/366	Competitive binding to thyroid hormone carrier protein transthyretin (TTR) leading to altered amphibian metamorphosis 
https://identifiers.org/aop.events/961	https://identifiers.org/aop.events/961	https://identifiers.org/aop/367	https://identifiers.org/aop/367	Competitive binding to thyroid hormone carrier protein thyroid binding globulin (TBG) leading to altered amphibian metamorphosis
https://identifiers.org/aop.events/281	https://identifiers.org/aop.events/281	https://identifiers.org/aop/367	https://identifiers.org/aop/367	Competitive binding to thyroid hormone carrier protein thyroid binding globulin (TBG) leading to altered amphibian metamorphosis
https://identifiers.org/aop.events/1825	https://identifiers.org/aop.events/1825	https://identifiers.org/aop/368	https://identifiers.org/aop/368	Cytochrome oxidase inhibition leading to olfactory nasal lesions
https://identifiers.org/aop.events/188	https://identifiers.org/aop.events/188	https://identifiers.org/aop/374	https://identifiers.org/aop/374	Binding of Sars-CoV-2 spike protein to ACE 2 receptors expressed on brain cells (neuronal and non-neuronal) leads to neuroinflammation resulting in encephalitis
https://identifiers.org/aop.events/352	https://identifiers.org/aop.events/352	https://identifiers.org/aop/374	https://identifiers.org/aop/374	Binding of Sars-CoV-2 spike protein to ACE 2 receptors expressed on brain cells (neuronal and non-neuronal) leads to neuroinflammation resulting in encephalitis
https://identifiers.org/aop.events/1493	https://identifiers.org/aop.events/1493	https://identifiers.org/aop/377	https://identifiers.org/aop/377	Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Multi Organ Failure involving Acute Respiratory Distress Syndrome (ARDS)
https://identifiers.org/aop.events/1496	https://identifiers.org/aop.events/1496	https://identifiers.org/aop/377	https://identifiers.org/aop/377	Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Multi Organ Failure involving Acute Respiratory Distress Syndrome (ARDS)
https://identifiers.org/aop.events/1848	https://identifiers.org/aop.events/1848	https://identifiers.org/aop/377	https://identifiers.org/aop/377	Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Multi Organ Failure involving Acute Respiratory Distress Syndrome (ARDS)
https://identifiers.org/aop.events/1708	https://identifiers.org/aop.events/1708	https://identifiers.org/aop/377	https://identifiers.org/aop/377	Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Multi Organ Failure involving Acute Respiratory Distress Syndrome (ARDS)
https://identifiers.org/aop.events/814	https://identifiers.org/aop.events/814	https://identifiers.org/aop/377	https://identifiers.org/aop/377	Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Multi Organ Failure involving Acute Respiratory Distress Syndrome (ARDS)
https://identifiers.org/aop.events/55	https://identifiers.org/aop.events/55	https://identifiers.org/aop/377	https://identifiers.org/aop/377	Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Multi Organ Failure involving Acute Respiratory Distress Syndrome (ARDS)
https://identifiers.org/aop.events/1857	https://identifiers.org/aop.events/1857	https://identifiers.org/aop/377	https://identifiers.org/aop/377	Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Multi Organ Failure involving Acute Respiratory Distress Syndrome (ARDS)
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/377	https://identifiers.org/aop/377	Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Multi Organ Failure involving Acute Respiratory Distress Syndrome (ARDS)
https://identifiers.org/aop.events/1895	https://identifiers.org/aop.events/1895	https://identifiers.org/aop/377	https://identifiers.org/aop/377	Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Multi Organ Failure involving Acute Respiratory Distress Syndrome (ARDS)
https://identifiers.org/aop.events/1846	https://identifiers.org/aop.events/1846	https://identifiers.org/aop/377	https://identifiers.org/aop/377	Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Multi Organ Failure involving Acute Respiratory Distress Syndrome (ARDS)
https://identifiers.org/aop.events/1392	https://identifiers.org/aop.events/1392	https://identifiers.org/aop/377	https://identifiers.org/aop/377	Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Multi Organ Failure involving Acute Respiratory Distress Syndrome (ARDS)
https://identifiers.org/aop.events/87	https://identifiers.org/aop.events/87	https://identifiers.org/aop/377	https://identifiers.org/aop/377	Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Multi Organ Failure involving Acute Respiratory Distress Syndrome (ARDS)
https://identifiers.org/aop.events/1868	https://identifiers.org/aop.events/1868	https://identifiers.org/aop/377	https://identifiers.org/aop/377	Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Multi Organ Failure involving Acute Respiratory Distress Syndrome (ARDS)
https://identifiers.org/aop.events/1825	https://identifiers.org/aop.events/1825	https://identifiers.org/aop/377	https://identifiers.org/aop/377	Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Multi Organ Failure involving Acute Respiratory Distress Syndrome (ARDS)
https://identifiers.org/aop.events/1869	https://identifiers.org/aop.events/1869	https://identifiers.org/aop/377	https://identifiers.org/aop/377	Dysregulated prolonged Toll Like Receptor 9 (TLR9) activation leading to Multi Organ Failure involving Acute Respiratory Distress Syndrome (ARDS)
https://identifiers.org/aop.events/1845	https://identifiers.org/aop.events/1845	https://identifiers.org/aop/379	https://identifiers.org/aop/379	Binding to ACE2 leading to thrombosis and disseminated intravascular coagulation
https://identifiers.org/aop.events/1869	https://identifiers.org/aop.events/1869	https://identifiers.org/aop/379	https://identifiers.org/aop/379	Binding to ACE2 leading to thrombosis and disseminated intravascular coagulation
https://identifiers.org/aop.events/1738	https://identifiers.org/aop.events/1738	https://identifiers.org/aop/379	https://identifiers.org/aop/379	Binding to ACE2 leading to thrombosis and disseminated intravascular coagulation
https://identifiers.org/aop.events/1846	https://identifiers.org/aop.events/1846	https://identifiers.org/aop/379	https://identifiers.org/aop/379	Binding to ACE2 leading to thrombosis and disseminated intravascular coagulation
https://identifiers.org/aop.events/1901	https://identifiers.org/aop.events/1901	https://identifiers.org/aop/379	https://identifiers.org/aop/379	Binding to ACE2 leading to thrombosis and disseminated intravascular coagulation
https://identifiers.org/aop.events/1847	https://identifiers.org/aop.events/1847	https://identifiers.org/aop/379	https://identifiers.org/aop/379	Binding to ACE2 leading to thrombosis and disseminated intravascular coagulation
https://identifiers.org/aop.events/1493	https://identifiers.org/aop.events/1493	https://identifiers.org/aop/38	https://identifiers.org/aop/38	Protein Alkylation leading to Liver Fibrosis
https://identifiers.org/aop.events/1492	https://identifiers.org/aop.events/1492	https://identifiers.org/aop/38	https://identifiers.org/aop/38	Protein Alkylation leading to Liver Fibrosis
https://identifiers.org/aop.events/265	https://identifiers.org/aop.events/265	https://identifiers.org/aop/38	https://identifiers.org/aop/38	Protein Alkylation leading to Liver Fibrosis
https://identifiers.org/aop.events/55	https://identifiers.org/aop.events/55	https://identifiers.org/aop/38	https://identifiers.org/aop/38	Protein Alkylation leading to Liver Fibrosis
https://identifiers.org/aop.events/1496	https://identifiers.org/aop.events/1496	https://identifiers.org/aop/382	https://identifiers.org/aop/382	Angiotensin II type 1 receptor (AT1R) agonism leading to lung fibrosis
https://identifiers.org/aop.events/1501	https://identifiers.org/aop.events/1501	https://identifiers.org/aop/383	https://identifiers.org/aop/383	Inhibition of Angiotensin-converting enzyme 2 leading to liver fibrosis
https://identifiers.org/aop.events/398	https://identifiers.org/aop.events/398	https://identifiers.org/aop/39	https://identifiers.org/aop/39	Covalent Binding, Protein, leading to Increase, Allergic Respiratory Hypersensitivity Response
https://identifiers.org/aop.events/1496	https://identifiers.org/aop.events/1496	https://identifiers.org/aop/39	https://identifiers.org/aop/39	Covalent Binding, Protein, leading to Increase, Allergic Respiratory Hypersensitivity Response
https://identifiers.org/aop.events/1867	https://identifiers.org/aop.events/1867	https://identifiers.org/aop/392	https://identifiers.org/aop/392	Decreased fibrinolysis and activated bradykinin system leading to hyperinflammation
https://identifiers.org/aop.events/1496	https://identifiers.org/aop.events/1496	https://identifiers.org/aop/392	https://identifiers.org/aop/392	Decreased fibrinolysis and activated bradykinin system leading to hyperinflammation
https://identifiers.org/aop.events/1868	https://identifiers.org/aop.events/1868	https://identifiers.org/aop/392	https://identifiers.org/aop/392	Decreased fibrinolysis and activated bradykinin system leading to hyperinflammation
https://identifiers.org/aop.events/1866	https://identifiers.org/aop.events/1866	https://identifiers.org/aop/392	https://identifiers.org/aop/392	Decreased fibrinolysis and activated bradykinin system leading to hyperinflammation
https://identifiers.org/aop.events/1847	https://identifiers.org/aop.events/1847	https://identifiers.org/aop/394	https://identifiers.org/aop/394	SARS-CoV-2 infection of olfactory epithelium leading to impaired olfactory function (short-term anosmia)
https://identifiers.org/aop.events/1738	https://identifiers.org/aop.events/1738	https://identifiers.org/aop/394	https://identifiers.org/aop/394	SARS-CoV-2 infection of olfactory epithelium leading to impaired olfactory function (short-term anosmia)
https://identifiers.org/aop.events/1738	https://identifiers.org/aop.events/1738	https://identifiers.org/aop/395	https://identifiers.org/aop/395	Binding of Sars-CoV-2 spike protein to ACE 2 receptors expressed on pericytes leads to disseminated intravascular coagulation resulting in cerebrovascular disease (stroke)
https://identifiers.org/aop.events/1846	https://identifiers.org/aop.events/1846	https://identifiers.org/aop/395	https://identifiers.org/aop/395	Binding of Sars-CoV-2 spike protein to ACE 2 receptors expressed on pericytes leads to disseminated intravascular coagulation resulting in cerebrovascular disease (stroke)
https://identifiers.org/aop.events/155	https://identifiers.org/aop.events/155	https://identifiers.org/aop/397	https://identifiers.org/aop/397	Bulky DNA adducts leading to mutations
https://identifiers.org/aop.events/1881	https://identifiers.org/aop.events/1881	https://identifiers.org/aop/398	https://identifiers.org/aop/398	Inhibition of ALDH1A (RALDH) leading to impaired fertility via disrupted meiotic initiation of fetal oogonia of the ovary
https://identifiers.org/aop.events/1880	https://identifiers.org/aop.events/1880	https://identifiers.org/aop/398	https://identifiers.org/aop/398	Inhibition of ALDH1A (RALDH) leading to impaired fertility via disrupted meiotic initiation of fetal oogonia of the ovary
https://identifiers.org/aop.events/1885	https://identifiers.org/aop.events/1885	https://identifiers.org/aop/399	https://identifiers.org/aop/399	Inhibition of Fyna leading to increased mortality via decreased eye size (Microphthalmos)
https://identifiers.org/aop.events/1884	https://identifiers.org/aop.events/1884	https://identifiers.org/aop/399	https://identifiers.org/aop/399	Inhibition of Fyna leading to increased mortality via decreased eye size (Microphthalmos)
https://identifiers.org/aop.events/398	https://identifiers.org/aop.events/398	https://identifiers.org/aop/40	https://identifiers.org/aop/40	Covalent Protein binding leading to Skin Sensitisation
https://identifiers.org/aop.events/826	https://identifiers.org/aop.events/826	https://identifiers.org/aop/40	https://identifiers.org/aop/40	Covalent Protein binding leading to Skin Sensitisation
https://identifiers.org/aop.events/1888	https://identifiers.org/aop.events/1888	https://identifiers.org/aop/400	https://identifiers.org/aop/400	Increased (ectopic) concentration of all-trans retinoic acid (ATRA) if fetal testis leading to reduced sperm count, males
https://identifiers.org/aop.events/1889	https://identifiers.org/aop.events/1889	https://identifiers.org/aop/400	https://identifiers.org/aop/400	Increased (ectopic) concentration of all-trans retinoic acid (ATRA) if fetal testis leading to reduced sperm count, males
https://identifiers.org/aop.events/277	https://identifiers.org/aop.events/277	https://identifiers.org/aop/402	https://identifiers.org/aop/402	Thyroid peroxidase (TPO) inhibition leads to periventricular heterotopia formation in the developing rat brain
https://identifiers.org/aop.events/1895	https://identifiers.org/aop.events/1895	https://identifiers.org/aop/406	https://identifiers.org/aop/406	SARS-CoV-2 infection leading to hyperinflammation
https://identifiers.org/aop.events/1847	https://identifiers.org/aop.events/1847	https://identifiers.org/aop/406	https://identifiers.org/aop/406	SARS-CoV-2 infection leading to hyperinflammation
https://identifiers.org/aop.events/1738	https://identifiers.org/aop.events/1738	https://identifiers.org/aop/406	https://identifiers.org/aop/406	SARS-CoV-2 infection leading to hyperinflammation
https://identifiers.org/aop.events/1868	https://identifiers.org/aop.events/1868	https://identifiers.org/aop/406	https://identifiers.org/aop/406	SARS-CoV-2 infection leading to hyperinflammation
https://identifiers.org/aop.events/1869	https://identifiers.org/aop.events/1869	https://identifiers.org/aop/406	https://identifiers.org/aop/406	SARS-CoV-2 infection leading to hyperinflammation
https://identifiers.org/aop.events/1869	https://identifiers.org/aop.events/1869	https://identifiers.org/aop/407	https://identifiers.org/aop/407	SARS-CoV-2 infection leading to pyroptosis
https://identifiers.org/aop.events/1967	https://identifiers.org/aop.events/1967	https://identifiers.org/aop/407	https://identifiers.org/aop/407	SARS-CoV-2 infection leading to pyroptosis
https://identifiers.org/aop.events/1895	https://identifiers.org/aop.events/1895	https://identifiers.org/aop/407	https://identifiers.org/aop/407	SARS-CoV-2 infection leading to pyroptosis
https://identifiers.org/aop.events/1847	https://identifiers.org/aop.events/1847	https://identifiers.org/aop/407	https://identifiers.org/aop/407	SARS-CoV-2 infection leading to pyroptosis
https://identifiers.org/aop.events/1738	https://identifiers.org/aop.events/1738	https://identifiers.org/aop/407	https://identifiers.org/aop/407	SARS-CoV-2 infection leading to pyroptosis
https://identifiers.org/aop.events/1496	https://identifiers.org/aop.events/1496	https://identifiers.org/aop/409	https://identifiers.org/aop/409	Frustrated phagocytosis leads to malignant mesothelioma
https://identifiers.org/aop.events/854	https://identifiers.org/aop.events/854	https://identifiers.org/aop/41	https://identifiers.org/aop/41	Sustained AhR Activation leading to Rodent Liver Tumours
https://identifiers.org/aop.events/165	https://identifiers.org/aop.events/165	https://identifiers.org/aop/41	https://identifiers.org/aop/41	Sustained AhR Activation leading to Rodent Liver Tumours
https://identifiers.org/aop.events/1647	https://identifiers.org/aop.events/1647	https://identifiers.org/aop/410	https://identifiers.org/aop/410	GSK3beta inactivation leading to increased mortality via defects in developing inner ear
https://identifiers.org/aop.events/1825	https://identifiers.org/aop.events/1825	https://identifiers.org/aop/410	https://identifiers.org/aop/410	GSK3beta inactivation leading to increased mortality via defects in developing inner ear
https://identifiers.org/aop.events/1392	https://identifiers.org/aop.events/1392	https://identifiers.org/aop/411	https://identifiers.org/aop/411	Oxidative stress Leading to Decreased Lung Function 
https://identifiers.org/aop.events/1908	https://identifiers.org/aop.events/1908	https://identifiers.org/aop/411	https://identifiers.org/aop/411	Oxidative stress Leading to Decreased Lung Function 
https://identifiers.org/aop.events/1857	https://identifiers.org/aop.events/1857	https://identifiers.org/aop/412	https://identifiers.org/aop/412	Endothelial cell dysfunction leading to thromboinflammation
https://identifiers.org/aop.events/87	https://identifiers.org/aop.events/87	https://identifiers.org/aop/412	https://identifiers.org/aop/412	Endothelial cell dysfunction leading to thromboinflammation
https://identifiers.org/aop.events/1501	https://identifiers.org/aop.events/1501	https://identifiers.org/aop/415	https://identifiers.org/aop/415	Aryl hydrocarbon receptor activation leading to lung fibrosis through IL-6 toxicity pathway
https://identifiers.org/aop.events/18	https://identifiers.org/aop.events/18	https://identifiers.org/aop/415	https://identifiers.org/aop/415	Aryl hydrocarbon receptor activation leading to lung fibrosis through IL-6 toxicity pathway
https://identifiers.org/aop.events/1457	https://identifiers.org/aop.events/1457	https://identifiers.org/aop/415	https://identifiers.org/aop/415	Aryl hydrocarbon receptor activation leading to lung fibrosis through IL-6 toxicity pathway
https://identifiers.org/aop.events/18	https://identifiers.org/aop.events/18	https://identifiers.org/aop/416	https://identifiers.org/aop/416	Aryl hydrocarbon receptor activation leading to lung cancer through IL-6 toxicity pathway
https://identifiers.org/aop.events/18	https://identifiers.org/aop.events/18	https://identifiers.org/aop/417	https://identifiers.org/aop/417	Aryl hydrocarbon receptor activation leading to lung cancer through AHR-ARNT toxicity pathway
https://identifiers.org/aop.events/1262	https://identifiers.org/aop.events/1262	https://identifiers.org/aop/419	https://identifiers.org/aop/419	Aryl hydrocarbon receptor activation leading to impaired lung function through P53 toxicity pathway
https://identifiers.org/aop.events/18	https://identifiers.org/aop.events/18	https://identifiers.org/aop/419	https://identifiers.org/aop/419	Aryl hydrocarbon receptor activation leading to impaired lung function through P53 toxicity pathway
https://identifiers.org/aop.events/277	https://identifiers.org/aop.events/277	https://identifiers.org/aop/42	https://identifiers.org/aop/42	Inhibition of Thyroperoxidase and Subsequent Adverse Neurodevelopmental Outcomes in Mammals
https://identifiers.org/aop.events/281	https://identifiers.org/aop.events/281	https://identifiers.org/aop/42	https://identifiers.org/aop/42	Inhibition of Thyroperoxidase and Subsequent Adverse Neurodevelopmental Outcomes in Mammals
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/423	https://identifiers.org/aop/423	 Toxicological mechanisms of hepatocyte apoptosis through the PARP1 dependent cell death pathway 
https://identifiers.org/aop.events/1392	https://identifiers.org/aop.events/1392	https://identifiers.org/aop/424	https://identifiers.org/aop/424	Oxidative stress Leading to Decreased Lung Function via CFTR dysfunction
https://identifiers.org/aop.events/1908	https://identifiers.org/aop.events/1908	https://identifiers.org/aop/424	https://identifiers.org/aop/424	Oxidative stress Leading to Decreased Lung Function via CFTR dysfunction
https://identifiers.org/aop.events/1908	https://identifiers.org/aop.events/1908	https://identifiers.org/aop/425	https://identifiers.org/aop/425	Oxidative Stress Leading to Decreased Lung Function via Decreased FOXJ1
https://identifiers.org/aop.events/1911	https://identifiers.org/aop.events/1911	https://identifiers.org/aop/425	https://identifiers.org/aop/425	Oxidative Stress Leading to Decreased Lung Function via Decreased FOXJ1
https://identifiers.org/aop.events/1392	https://identifiers.org/aop.events/1392	https://identifiers.org/aop/425	https://identifiers.org/aop/425	Oxidative Stress Leading to Decreased Lung Function via Decreased FOXJ1
https://identifiers.org/aop.events/1738	https://identifiers.org/aop.events/1738	https://identifiers.org/aop/426	https://identifiers.org/aop/426	SARS-CoV-2 spike protein binding to ACE2 receptors expressed on pericytes leads to endothelial cell dysfunction, microvascular injury and myocardial infarction. 
https://identifiers.org/aop.events/1392	https://identifiers.org/aop.events/1392	https://identifiers.org/aop/429	https://identifiers.org/aop/429	A cholesterol/glucose dysmetabolism initiated Tau-driven AOP toward memory loss (AO) in sporadic Alzheimer's Disease with plausible MIE's plug-ins for environmental neurotoxicants
https://identifiers.org/aop.events/188	https://identifiers.org/aop.events/188	https://identifiers.org/aop/429	https://identifiers.org/aop/429	A cholesterol/glucose dysmetabolism initiated Tau-driven AOP toward memory loss (AO) in sporadic Alzheimer's Disease with plausible MIE's plug-ins for environmental neurotoxicants
https://identifiers.org/aop.events/28	https://identifiers.org/aop.events/28	https://identifiers.org/aop/43	https://identifiers.org/aop/43	Disruption of VEGFR Signaling Leading to Developmental Defects
https://identifiers.org/aop.events/305	https://identifiers.org/aop.events/305	https://identifiers.org/aop/43	https://identifiers.org/aop/43	Disruption of VEGFR Signaling Leading to Developmental Defects
https://identifiers.org/aop.events/1738	https://identifiers.org/aop.events/1738	https://identifiers.org/aop/430	https://identifiers.org/aop/430	Binding of SARS-CoV-2 to ACE2 leads to viral infection proliferation
https://identifiers.org/aop.events/1901	https://identifiers.org/aop.events/1901	https://identifiers.org/aop/430	https://identifiers.org/aop/430	Binding of SARS-CoV-2 to ACE2 leads to viral infection proliferation
https://identifiers.org/aop.events/1847	https://identifiers.org/aop.events/1847	https://identifiers.org/aop/430	https://identifiers.org/aop/430	Binding of SARS-CoV-2 to ACE2 leads to viral infection proliferation
https://identifiers.org/aop.events/155	https://identifiers.org/aop.events/155	https://identifiers.org/aop/432	https://identifiers.org/aop/432	Deposition of Energy by Ionizing Radiation leading to Acute Myeloid Leukemia
https://identifiers.org/aop.events/1493	https://identifiers.org/aop.events/1493	https://identifiers.org/aop/432	https://identifiers.org/aop/432	Deposition of Energy by Ionizing Radiation leading to Acute Myeloid Leukemia
https://identifiers.org/aop.events/1632	https://identifiers.org/aop.events/1632	https://identifiers.org/aop/432	https://identifiers.org/aop/432	Deposition of Energy by Ionizing Radiation leading to Acute Myeloid Leukemia
https://identifiers.org/aop.events/1557	https://identifiers.org/aop.events/1557	https://identifiers.org/aop/436	https://identifiers.org/aop/436	Inhibition of RALDH2 causes reduced all-trans retinoic acid levels, leading to transposition of the great arteries
https://identifiers.org/aop.events/1880	https://identifiers.org/aop.events/1880	https://identifiers.org/aop/436	https://identifiers.org/aop/436	Inhibition of RALDH2 causes reduced all-trans retinoic acid levels, leading to transposition of the great arteries
https://identifiers.org/aop.events/1881	https://identifiers.org/aop.events/1881	https://identifiers.org/aop/436	https://identifiers.org/aop/436	Inhibition of RALDH2 causes reduced all-trans retinoic acid levels, leading to transposition of the great arteries
https://identifiers.org/aop.events/1969	https://identifiers.org/aop.events/1969	https://identifiers.org/aop/437	https://identifiers.org/aop/437	Inhibition of mitochondrial electron transport chain (ETC) complexes leading to kidney toxicity
https://identifiers.org/aop.events/105	https://identifiers.org/aop.events/105	https://identifiers.org/aop/437	https://identifiers.org/aop/437	Inhibition of mitochondrial electron transport chain (ETC) complexes leading to kidney toxicity
https://identifiers.org/aop.events/709	https://identifiers.org/aop.events/709	https://identifiers.org/aop/437	https://identifiers.org/aop/437	Inhibition of mitochondrial electron transport chain (ETC) complexes leading to kidney toxicity
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/437	https://identifiers.org/aop/437	Inhibition of mitochondrial electron transport chain (ETC) complexes leading to kidney toxicity
https://identifiers.org/aop.events/814	https://identifiers.org/aop.events/814	https://identifiers.org/aop/437	https://identifiers.org/aop/437	Inhibition of mitochondrial electron transport chain (ETC) complexes leading to kidney toxicity
https://identifiers.org/aop.events/149	https://identifiers.org/aop.events/149	https://identifiers.org/aop/439	https://identifiers.org/aop/439	Activation of the AhR leading to metastatic breast cancer 
https://identifiers.org/aop.events/18	https://identifiers.org/aop.events/18	https://identifiers.org/aop/439	https://identifiers.org/aop/439	Activation of the AhR leading to metastatic breast cancer 
https://identifiers.org/aop.events/1971	https://identifiers.org/aop.events/1971	https://identifiers.org/aop/439	https://identifiers.org/aop/439	Activation of the AhR leading to metastatic breast cancer 
https://identifiers.org/aop.events/1262	https://identifiers.org/aop.events/1262	https://identifiers.org/aop/439	https://identifiers.org/aop/439	Activation of the AhR leading to metastatic breast cancer 
https://identifiers.org/aop.events/1046	https://identifiers.org/aop.events/1046	https://identifiers.org/aop/440	https://identifiers.org/aop/440	Hypothalamus estrogen receptors activity suppression leading to ovarian cancer via ovarian epithelial cell hyperplasia
https://identifiers.org/aop.events/1262	https://identifiers.org/aop.events/1262	https://identifiers.org/aop/441	https://identifiers.org/aop/441	Ionizing radiation-induced DNA damage leads to microcephaly via apoptosis and premature cell differentiation
https://identifiers.org/aop.events/1974	https://identifiers.org/aop.events/1974	https://identifiers.org/aop/441	https://identifiers.org/aop/441	Ionizing radiation-induced DNA damage leads to microcephaly via apoptosis and premature cell differentiation
https://identifiers.org/aop.events/1983	https://identifiers.org/aop.events/1983	https://identifiers.org/aop/442	https://identifiers.org/aop/442	Binding to voltage gate sodium channels during development leads to cognitive impairment 
https://identifiers.org/aop.events/1980	https://identifiers.org/aop.events/1980	https://identifiers.org/aop/443	https://identifiers.org/aop/443	 DNA damage and mutations leading to Metastatic Breast Cancer
https://identifiers.org/aop.events/155	https://identifiers.org/aop.events/155	https://identifiers.org/aop/443	https://identifiers.org/aop/443	 DNA damage and mutations leading to Metastatic Breast Cancer
https://identifiers.org/aop.events/1457	https://identifiers.org/aop.events/1457	https://identifiers.org/aop/443	https://identifiers.org/aop/443	 DNA damage and mutations leading to Metastatic Breast Cancer
https://identifiers.org/aop.events/1981	https://identifiers.org/aop.events/1981	https://identifiers.org/aop/443	https://identifiers.org/aop/443	 DNA damage and mutations leading to Metastatic Breast Cancer
https://identifiers.org/aop.events/1632	https://identifiers.org/aop.events/1632	https://identifiers.org/aop/444	https://identifiers.org/aop/444	Ionizing radiation leads to reduced reproduction in Eisenia fetida via reduced spermatogenesis and cocoon hatchability
https://identifiers.org/aop.events/202	https://identifiers.org/aop.events/202	https://identifiers.org/aop/447	https://identifiers.org/aop/447	Kidney failure induced by inhibition of mitochondrial electron transfer chain through apoptosis, inflammation and oxidative stress pathways
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/447	https://identifiers.org/aop/447	Kidney failure induced by inhibition of mitochondrial electron transfer chain through apoptosis, inflammation and oxidative stress pathways
https://identifiers.org/aop.events/105	https://identifiers.org/aop.events/105	https://identifiers.org/aop/447	https://identifiers.org/aop/447	Kidney failure induced by inhibition of mitochondrial electron transfer chain through apoptosis, inflammation and oxidative stress pathways
https://identifiers.org/aop.events/814	https://identifiers.org/aop.events/814	https://identifiers.org/aop/447	https://identifiers.org/aop/447	Kidney failure induced by inhibition of mitochondrial electron transfer chain through apoptosis, inflammation and oxidative stress pathways
https://identifiers.org/aop.events/1502	https://identifiers.org/aop.events/1502	https://identifiers.org/aop/449	https://identifiers.org/aop/449	Ceramide synthase inhibition leading to neural tube defects 
https://identifiers.org/aop.events/352	https://identifiers.org/aop.events/352	https://identifiers.org/aop/450	https://identifiers.org/aop/450	 Inhibition of AChE and activation of CYP2E1 leading to sensory axonal peripheral neuropathy and mortality
https://identifiers.org/aop.events/618	https://identifiers.org/aop.events/618	https://identifiers.org/aop/450	https://identifiers.org/aop/450	 Inhibition of AChE and activation of CYP2E1 leading to sensory axonal peripheral neuropathy and mortality
https://identifiers.org/aop.events/1391	https://identifiers.org/aop.events/1391	https://identifiers.org/aop/450	https://identifiers.org/aop/450	 Inhibition of AChE and activation of CYP2E1 leading to sensory axonal peripheral neuropathy and mortality
https://identifiers.org/aop.events/1495	https://identifiers.org/aop.events/1495	https://identifiers.org/aop/451	https://identifiers.org/aop/451	Interaction with lung resident cell membrane components leads to lung cancer
https://identifiers.org/aop.events/1496	https://identifiers.org/aop.events/1496	https://identifiers.org/aop/451	https://identifiers.org/aop/451	Interaction with lung resident cell membrane components leads to lung cancer
https://identifiers.org/aop.events/1457	https://identifiers.org/aop.events/1457	https://identifiers.org/aop/452	https://identifiers.org/aop/452	Adverse outcome pathway of PM-induced respiratory toxicity
https://identifiers.org/aop.events/1262	https://identifiers.org/aop.events/1262	https://identifiers.org/aop/452	https://identifiers.org/aop/452	Adverse outcome pathway of PM-induced respiratory toxicity
https://identifiers.org/aop.events/1392	https://identifiers.org/aop.events/1392	https://identifiers.org/aop/452	https://identifiers.org/aop/452	Adverse outcome pathway of PM-induced respiratory toxicity
https://identifiers.org/aop.events/944	https://identifiers.org/aop.events/944	https://identifiers.org/aop/455	https://identifiers.org/aop/455	Aryl hydrocarbon receptor activation leading to early life stage mortality via sox9 repression induced impeded craniofacial development
https://identifiers.org/aop.events/18	https://identifiers.org/aop.events/18	https://identifiers.org/aop/455	https://identifiers.org/aop/455	Aryl hydrocarbon receptor activation leading to early life stage mortality via sox9 repression induced impeded craniofacial development
https://identifiers.org/aop.events/2020	https://identifiers.org/aop.events/2020	https://identifiers.org/aop/455	https://identifiers.org/aop/455	Aryl hydrocarbon receptor activation leading to early life stage mortality via sox9 repression induced impeded craniofacial development
https://identifiers.org/aop.events/944	https://identifiers.org/aop.events/944	https://identifiers.org/aop/456	https://identifiers.org/aop/456	Aryl hydrocarbon receptor activation leading to early life stage mortality via sox9 repression induced cardiovascular toxicity
https://identifiers.org/aop.events/2020	https://identifiers.org/aop.events/2020	https://identifiers.org/aop/456	https://identifiers.org/aop/456	Aryl hydrocarbon receptor activation leading to early life stage mortality via sox9 repression induced cardiovascular toxicity
https://identifiers.org/aop.events/18	https://identifiers.org/aop.events/18	https://identifiers.org/aop/456	https://identifiers.org/aop/456	Aryl hydrocarbon receptor activation leading to early life stage mortality via sox9 repression induced cardiovascular toxicity
https://identifiers.org/aop.events/1969	https://identifiers.org/aop.events/1969	https://identifiers.org/aop/457	https://identifiers.org/aop/457	Succinate dehydrogenase inhibition leading to increased insulin resistance through reduction in circulating thyroxine
https://identifiers.org/aop.events/281	https://identifiers.org/aop.events/281	https://identifiers.org/aop/457	https://identifiers.org/aop/457	Succinate dehydrogenase inhibition leading to increased insulin resistance through reduction in circulating thyroxine
https://identifiers.org/aop.events/277	https://identifiers.org/aop.events/277	https://identifiers.org/aop/457	https://identifiers.org/aop/457	Succinate dehydrogenase inhibition leading to increased insulin resistance through reduction in circulating thyroxine
https://identifiers.org/aop.events/2118	https://identifiers.org/aop.events/2118	https://identifiers.org/aop/457	https://identifiers.org/aop/457	Succinate dehydrogenase inhibition leading to increased insulin resistance through reduction in circulating thyroxine
https://identifiers.org/aop.events/18	https://identifiers.org/aop.events/18	https://identifiers.org/aop/458	https://identifiers.org/aop/458	AhR activation in the liver leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals
https://identifiers.org/aop.events/281	https://identifiers.org/aop.events/281	https://identifiers.org/aop/458	https://identifiers.org/aop/458	AhR activation in the liver leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals
https://identifiers.org/aop.events/961	https://identifiers.org/aop.events/961	https://identifiers.org/aop/458	https://identifiers.org/aop/458	AhR activation in the liver leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals
https://identifiers.org/aop.events/18	https://identifiers.org/aop.events/18	https://identifiers.org/aop/459	https://identifiers.org/aop/459	AhR activation in the thyroid leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals
https://identifiers.org/aop.events/850	https://identifiers.org/aop.events/850	https://identifiers.org/aop/459	https://identifiers.org/aop/459	AhR activation in the thyroid leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals
https://identifiers.org/aop.events/277	https://identifiers.org/aop.events/277	https://identifiers.org/aop/459	https://identifiers.org/aop/459	AhR activation in the thyroid leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals
https://identifiers.org/aop.events/1969	https://identifiers.org/aop.events/1969	https://identifiers.org/aop/459	https://identifiers.org/aop/459	AhR activation in the thyroid leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals
https://identifiers.org/aop.events/281	https://identifiers.org/aop.events/281	https://identifiers.org/aop/459	https://identifiers.org/aop/459	AhR activation in the thyroid leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals
https://identifiers.org/aop.events/376	https://identifiers.org/aop.events/376	https://identifiers.org/aop/46	https://identifiers.org/aop/46	AFB1: Mutagenic Mode-of-Action leading to Hepatocellular Carcinoma (HCC)
https://identifiers.org/aop.events/493	https://identifiers.org/aop.events/493	https://identifiers.org/aop/46	https://identifiers.org/aop/46	AFB1: Mutagenic Mode-of-Action leading to Hepatocellular Carcinoma (HCC)
https://identifiers.org/aop.events/409	https://identifiers.org/aop.events/409	https://identifiers.org/aop/46	https://identifiers.org/aop/46	AFB1: Mutagenic Mode-of-Action leading to Hepatocellular Carcinoma (HCC)
https://identifiers.org/aop.events/378	https://identifiers.org/aop.events/378	https://identifiers.org/aop/46	https://identifiers.org/aop/46	AFB1: Mutagenic Mode-of-Action leading to Hepatocellular Carcinoma (HCC)
https://identifiers.org/aop.events/2044	https://identifiers.org/aop.events/2044	https://identifiers.org/aop/460	https://identifiers.org/aop/460	Antagonism of Smoothened receptor leading to orofacial clefting
https://identifiers.org/aop.events/2027	https://identifiers.org/aop.events/2027	https://identifiers.org/aop/460	https://identifiers.org/aop/460	Antagonism of Smoothened receptor leading to orofacial clefting
https://identifiers.org/aop.events/1262	https://identifiers.org/aop.events/1262	https://identifiers.org/aop/460	https://identifiers.org/aop/460	Antagonism of Smoothened receptor leading to orofacial clefting
https://identifiers.org/aop.events/2040	https://identifiers.org/aop.events/2040	https://identifiers.org/aop/460	https://identifiers.org/aop/460	Antagonism of Smoothened receptor leading to orofacial clefting
https://identifiers.org/aop.events/2043	https://identifiers.org/aop.events/2043	https://identifiers.org/aop/460	https://identifiers.org/aop/460	Antagonism of Smoothened receptor leading to orofacial clefting
https://identifiers.org/aop.events/1392	https://identifiers.org/aop.events/1392	https://identifiers.org/aop/464	https://identifiers.org/aop/464	Calcium overload in dopaminergic neurons of the substantia nigra leading to parkinsonian motor deficits
https://identifiers.org/aop.events/1825	https://identifiers.org/aop.events/1825	https://identifiers.org/aop/464	https://identifiers.org/aop/464	Calcium overload in dopaminergic neurons of the substantia nigra leading to parkinsonian motor deficits
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/464	https://identifiers.org/aop/464	Calcium overload in dopaminergic neurons of the substantia nigra leading to parkinsonian motor deficits
https://identifiers.org/aop.events/1512	https://identifiers.org/aop.events/1512	https://identifiers.org/aop/464	https://identifiers.org/aop/464	Calcium overload in dopaminergic neurons of the substantia nigra leading to parkinsonian motor deficits
https://identifiers.org/aop.events/1901	https://identifiers.org/aop.events/1901	https://identifiers.org/aop/468	https://identifiers.org/aop/468	Binding of SARS-CoV-2 to ACE2 leads to hyperinflammation (via cell death)
https://identifiers.org/aop.events/1847	https://identifiers.org/aop.events/1847	https://identifiers.org/aop/468	https://identifiers.org/aop/468	Binding of SARS-CoV-2 to ACE2 leads to hyperinflammation (via cell death)
https://identifiers.org/aop.events/1496	https://identifiers.org/aop.events/1496	https://identifiers.org/aop/468	https://identifiers.org/aop/468	Binding of SARS-CoV-2 to ACE2 leads to hyperinflammation (via cell death)
https://identifiers.org/aop.events/1868	https://identifiers.org/aop.events/1868	https://identifiers.org/aop/468	https://identifiers.org/aop/468	Binding of SARS-CoV-2 to ACE2 leads to hyperinflammation (via cell death)
https://identifiers.org/aop.events/1738	https://identifiers.org/aop.events/1738	https://identifiers.org/aop/468	https://identifiers.org/aop/468	Binding of SARS-CoV-2 to ACE2 leads to hyperinflammation (via cell death)
https://identifiers.org/aop.events/1825	https://identifiers.org/aop.events/1825	https://identifiers.org/aop/468	https://identifiers.org/aop/468	Binding of SARS-CoV-2 to ACE2 leads to hyperinflammation (via cell death)
https://identifiers.org/aop.events/2067	https://identifiers.org/aop.events/2067	https://identifiers.org/aop/470	https://identifiers.org/aop/470	Deposition of energy leads to vascular remodeling
https://identifiers.org/aop.events/2069	https://identifiers.org/aop.events/2069	https://identifiers.org/aop/470	https://identifiers.org/aop/470	Deposition of energy leads to vascular remodeling
https://identifiers.org/aop.events/1392	https://identifiers.org/aop.events/1392	https://identifiers.org/aop/470	https://identifiers.org/aop/470	Deposition of energy leads to vascular remodeling
https://identifiers.org/aop.events/1493	https://identifiers.org/aop.events/1493	https://identifiers.org/aop/470	https://identifiers.org/aop/470	Deposition of energy leads to vascular remodeling
https://identifiers.org/aop.events/352	https://identifiers.org/aop.events/352	https://identifiers.org/aop/471	https://identifiers.org/aop/471	Various neuronal effects induced by elavl3, sox10, and mbp
https://identifiers.org/aop.events/618	https://identifiers.org/aop.events/618	https://identifiers.org/aop/471	https://identifiers.org/aop/471	Various neuronal effects induced by elavl3, sox10, and mbp
https://identifiers.org/aop.events/188	https://identifiers.org/aop.events/188	https://identifiers.org/aop/471	https://identifiers.org/aop/471	Various neuronal effects induced by elavl3, sox10, and mbp
https://identifiers.org/aop.events/1632	https://identifiers.org/aop.events/1632	https://identifiers.org/aop/473	https://identifiers.org/aop/473	Energy deposition from internalized Ra-226 decay lower oxygen binding capacity of hemocyanin
https://identifiers.org/aop.events/875	https://identifiers.org/aop.events/875	https://identifiers.org/aop/475	https://identifiers.org/aop/475	Binding of chemicals to ionotropic glutamate receptors leads to impairment of learning and memory via loss of drebrin from dendritic spines of neurons
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/476	https://identifiers.org/aop/476	Adverse Outcome Pathways diagram related to PBDEs associated male reproductive toxicity
https://identifiers.org/aop.events/1262	https://identifiers.org/aop.events/1262	https://identifiers.org/aop/476	https://identifiers.org/aop/476	Adverse Outcome Pathways diagram related to PBDEs associated male reproductive toxicity
https://identifiers.org/aop.events/1392	https://identifiers.org/aop.events/1392	https://identifiers.org/aop/478	https://identifiers.org/aop/478	Deposition of energy leading to occurrence of cataracts
https://identifiers.org/aop.events/1634	https://identifiers.org/aop.events/1634	https://identifiers.org/aop/478	https://identifiers.org/aop/478	Deposition of energy leading to occurrence of cataracts
https://identifiers.org/aop.events/155	https://identifiers.org/aop.events/155	https://identifiers.org/aop/478	https://identifiers.org/aop/478	Deposition of energy leading to occurrence of cataracts
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/479	https://identifiers.org/aop/479	Mitochondrial complexes inhibition leading to left ventricular function decrease via increased myocardial oxidative stress
https://identifiers.org/aop.events/105	https://identifiers.org/aop.events/105	https://identifiers.org/aop/479	https://identifiers.org/aop/479	Mitochondrial complexes inhibition leading to left ventricular function decrease via increased myocardial oxidative stress
https://identifiers.org/aop.events/1392	https://identifiers.org/aop.events/1392	https://identifiers.org/aop/479	https://identifiers.org/aop/479	Mitochondrial complexes inhibition leading to left ventricular function decrease via increased myocardial oxidative stress
https://identifiers.org/aop.events/55	https://identifiers.org/aop.events/55	https://identifiers.org/aop/479	https://identifiers.org/aop/479	Mitochondrial complexes inhibition leading to left ventricular function decrease via increased myocardial oxidative stress
https://identifiers.org/aop.events/352	https://identifiers.org/aop.events/352	https://identifiers.org/aop/48	https://identifiers.org/aop/48	Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.
https://identifiers.org/aop.events/188	https://identifiers.org/aop.events/188	https://identifiers.org/aop/48	https://identifiers.org/aop/48	Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.
https://identifiers.org/aop.events/875	https://identifiers.org/aop.events/875	https://identifiers.org/aop/48	https://identifiers.org/aop/48	Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/48	https://identifiers.org/aop/48	Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.
https://identifiers.org/aop.events/55	https://identifiers.org/aop.events/55	https://identifiers.org/aop/48	https://identifiers.org/aop/48	Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.
https://identifiers.org/aop.events/618	https://identifiers.org/aop.events/618	https://identifiers.org/aop/48	https://identifiers.org/aop/48	Binding of agonists to ionotropic glutamate receptors in adult brain causes excitotoxicity that mediates neuronal cell death, contributing to learning and memory impairment.
https://identifiers.org/aop.events/105	https://identifiers.org/aop.events/105	https://identifiers.org/aop/480	https://identifiers.org/aop/480	Mitochondrial complexes inhibition leading to heart failure via decreased ATP production
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/480	https://identifiers.org/aop/480	Mitochondrial complexes inhibition leading to heart failure via decreased ATP production
https://identifiers.org/aop.events/1458	https://identifiers.org/aop.events/1458	https://identifiers.org/aop/481	https://identifiers.org/aop/481	AOPs of amorphous silica nanoparticles: ROS-mediated oxidative stress increased respiratory dysfunction and diseases.
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/481	https://identifiers.org/aop/481	AOPs of amorphous silica nanoparticles: ROS-mediated oxidative stress increased respiratory dysfunction and diseases.
https://identifiers.org/aop.events/1392	https://identifiers.org/aop.events/1392	https://identifiers.org/aop/481	https://identifiers.org/aop/481	AOPs of amorphous silica nanoparticles: ROS-mediated oxidative stress increased respiratory dysfunction and diseases.
https://identifiers.org/aop.events/2089	https://identifiers.org/aop.events/2089	https://identifiers.org/aop/482	https://identifiers.org/aop/482	Deposition of energy leading to occurrence of bone loss
https://identifiers.org/aop.events/1392	https://identifiers.org/aop.events/1392	https://identifiers.org/aop/482	https://identifiers.org/aop/482	Deposition of energy leading to occurrence of bone loss
https://identifiers.org/aop.events/1825	https://identifiers.org/aop.events/1825	https://identifiers.org/aop/482	https://identifiers.org/aop/482	Deposition of energy leading to occurrence of bone loss
https://identifiers.org/aop.events/2090	https://identifiers.org/aop.events/2090	https://identifiers.org/aop/482	https://identifiers.org/aop/482	Deposition of energy leading to occurrence of bone loss
https://identifiers.org/aop.events/2097	https://identifiers.org/aop.events/2097	https://identifiers.org/aop/483	https://identifiers.org/aop/483	Deposition of Energy Leading to Learning and Memory Impairment
https://identifiers.org/aop.events/1492	https://identifiers.org/aop.events/1492	https://identifiers.org/aop/483	https://identifiers.org/aop/483	Deposition of Energy Leading to Learning and Memory Impairment
https://identifiers.org/aop.events/1392	https://identifiers.org/aop.events/1392	https://identifiers.org/aop/483	https://identifiers.org/aop/483	Deposition of Energy Leading to Learning and Memory Impairment
https://identifiers.org/aop.events/1869	https://identifiers.org/aop.events/1869	https://identifiers.org/aop/488	https://identifiers.org/aop/488	Increased reactive oxygen species production leading to decreased cognitive function
https://identifiers.org/aop.events/55	https://identifiers.org/aop.events/55	https://identifiers.org/aop/490	https://identifiers.org/aop/490	Co-activation of IP3R and RyR leads to socio-economic burden through reduced IQ and non-cholinergic mechanisms
https://identifiers.org/aop.events/188	https://identifiers.org/aop.events/188	https://identifiers.org/aop/490	https://identifiers.org/aop/490	Co-activation of IP3R and RyR leads to socio-economic burden through reduced IQ and non-cholinergic mechanisms
https://identifiers.org/aop.events/1262	https://identifiers.org/aop.events/1262	https://identifiers.org/aop/491	https://identifiers.org/aop/491	Decrease, GLI1/2 target gene expression leads to orofacial clefting 
https://identifiers.org/aop.events/2040	https://identifiers.org/aop.events/2040	https://identifiers.org/aop/491	https://identifiers.org/aop/491	Decrease, GLI1/2 target gene expression leads to orofacial clefting 
https://identifiers.org/aop.events/2043	https://identifiers.org/aop.events/2043	https://identifiers.org/aop/491	https://identifiers.org/aop/491	Decrease, GLI1/2 target gene expression leads to orofacial clefting 
https://identifiers.org/aop.events/1501	https://identifiers.org/aop.events/1501	https://identifiers.org/aop/494	https://identifiers.org/aop/494	AhR activation leading to liver fibrosis 
https://identifiers.org/aop.events/55	https://identifiers.org/aop.events/55	https://identifiers.org/aop/494	https://identifiers.org/aop/494	AhR activation leading to liver fibrosis 
https://identifiers.org/aop.events/18	https://identifiers.org/aop.events/18	https://identifiers.org/aop/494	https://identifiers.org/aop/494	AhR activation leading to liver fibrosis 
https://identifiers.org/aop.events/265	https://identifiers.org/aop.events/265	https://identifiers.org/aop/494	https://identifiers.org/aop/494	AhR activation leading to liver fibrosis 
https://identifiers.org/aop.events/854	https://identifiers.org/aop.events/854	https://identifiers.org/aop/495	https://identifiers.org/aop/495	Androgen receptor activation leading to prostate cancer
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/497	https://identifiers.org/aop/497	ERa inactivation alters mitochondrial functions and insulin signalling in skeletal muscle and leads to insulin resistance and metabolic syndrome
https://identifiers.org/aop.events/1339	https://identifiers.org/aop.events/1339	https://identifiers.org/aop/499	https://identifiers.org/aop/499	Activation of MEK-ERK1/2 leads to deficits in learning and cognition via disrupted neurotransmitter release
https://identifiers.org/aop.events/2146	https://identifiers.org/aop.events/2146	https://identifiers.org/aop/499	https://identifiers.org/aop/499	Activation of MEK-ERK1/2 leads to deficits in learning and cognition via disrupted neurotransmitter release
https://identifiers.org/aop.events/1339	https://identifiers.org/aop.events/1339	https://identifiers.org/aop/500	https://identifiers.org/aop/500	Activation of MEK-ERK1/2 leads to deficits in learning and cognition via ROS and apoptosis
https://identifiers.org/aop.events/2146	https://identifiers.org/aop.events/2146	https://identifiers.org/aop/500	https://identifiers.org/aop/500	Activation of MEK-ERK1/2 leads to deficits in learning and cognition via ROS and apoptosis
https://identifiers.org/aop.events/1262	https://identifiers.org/aop.events/1262	https://identifiers.org/aop/500	https://identifiers.org/aop/500	Activation of MEK-ERK1/2 leads to deficits in learning and cognition via ROS and apoptosis
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/500	https://identifiers.org/aop/500	Activation of MEK-ERK1/2 leads to deficits in learning and cognition via ROS and apoptosis
https://identifiers.org/aop.events/352	https://identifiers.org/aop.events/352	https://identifiers.org/aop/500	https://identifiers.org/aop/500	Activation of MEK-ERK1/2 leads to deficits in learning and cognition via ROS and apoptosis
https://identifiers.org/aop.events/1262	https://identifiers.org/aop.events/1262	https://identifiers.org/aop/502	https://identifiers.org/aop/502	Decrease, cholesterol synthesis leads to orofacial clefting
https://identifiers.org/aop.events/2043	https://identifiers.org/aop.events/2043	https://identifiers.org/aop/502	https://identifiers.org/aop/502	Decrease, cholesterol synthesis leads to orofacial clefting
https://identifiers.org/aop.events/2040	https://identifiers.org/aop.events/2040	https://identifiers.org/aop/502	https://identifiers.org/aop/502	Decrease, cholesterol synthesis leads to orofacial clefting
https://identifiers.org/aop.events/149	https://identifiers.org/aop.events/149	https://identifiers.org/aop/505	https://identifiers.org/aop/505	Reactive Oxygen Species (ROS) formation leads to cancer via inflammation pathway
https://identifiers.org/aop.events/1513	https://identifiers.org/aop.events/1513	https://identifiers.org/aop/505	https://identifiers.org/aop/505	Reactive Oxygen Species (ROS) formation leads to cancer via inflammation pathway
https://identifiers.org/aop.events/1392	https://identifiers.org/aop.events/1392	https://identifiers.org/aop/505	https://identifiers.org/aop/505	Reactive Oxygen Species (ROS) formation leads to cancer via inflammation pathway
https://identifiers.org/aop.events/2180	https://identifiers.org/aop.events/2180	https://identifiers.org/aop/506	https://identifiers.org/aop/506	Binding of Influenza A Virus (IAV) to Sialic Acid Glycan Receptor leads to viral infection proliferation
https://identifiers.org/aop.events/2192	https://identifiers.org/aop.events/2192	https://identifiers.org/aop/506	https://identifiers.org/aop/506	Binding of Influenza A Virus (IAV) to Sialic Acid Glycan Receptor leads to viral infection proliferation
https://identifiers.org/aop.events/1969	https://identifiers.org/aop.events/1969	https://identifiers.org/aop/507	https://identifiers.org/aop/507	Nrf2 inhibition leading to vascular disrupting effects via inflammation pathway
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/509	https://identifiers.org/aop/509	Nrf2 inhibition leading to vascular disrupting effects through activating apoptosis signal pathway and mitochondrial dysfunction
https://identifiers.org/aop.events/1969	https://identifiers.org/aop.events/1969	https://identifiers.org/aop/509	https://identifiers.org/aop/509	Nrf2 inhibition leading to vascular disrupting effects through activating apoptosis signal pathway and mitochondrial dysfunction
https://identifiers.org/aop.events/1969	https://identifiers.org/aop.events/1969	https://identifiers.org/aop/510	https://identifiers.org/aop/510	Demethylation of PPAR promotor leading to vascular disrupting effects
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/511	https://identifiers.org/aop/511	The AOP framework on ROS-mediated oxidative stress induced vascular disrupting effects 
https://identifiers.org/aop.events/1969	https://identifiers.org/aop.events/1969	https://identifiers.org/aop/511	https://identifiers.org/aop/511	The AOP framework on ROS-mediated oxidative stress induced vascular disrupting effects 
https://identifiers.org/aop.events/233	https://identifiers.org/aop.events/233	https://identifiers.org/aop/513	https://identifiers.org/aop/513	Reactive Oxygen (ROS) formation leads to cancer via Peroxisome proliferation-activated receptor (PPAR) pathway
https://identifiers.org/aop.events/1513	https://identifiers.org/aop.events/1513	https://identifiers.org/aop/513	https://identifiers.org/aop/513	Reactive Oxygen (ROS) formation leads to cancer via Peroxisome proliferation-activated receptor (PPAR) pathway
https://identifiers.org/aop.events/291	https://identifiers.org/aop.events/291	https://identifiers.org/aop/517	https://identifiers.org/aop/517	Pregnane X Receptor (PXR) activation leads to liver steatosis
https://identifiers.org/aop.events/2199	https://identifiers.org/aop.events/2199	https://identifiers.org/aop/518	https://identifiers.org/aop/518	Liver X Receptor (LXR) activation leads to liver steatosis
https://identifiers.org/aop.events/89	https://identifiers.org/aop.events/89	https://identifiers.org/aop/518	https://identifiers.org/aop/518	Liver X Receptor (LXR) activation leads to liver steatosis
https://identifiers.org/aop.events/291	https://identifiers.org/aop.events/291	https://identifiers.org/aop/518	https://identifiers.org/aop/518	Liver X Receptor (LXR) activation leads to liver steatosis
https://identifiers.org/aop.events/167	https://identifiers.org/aop.events/167	https://identifiers.org/aop/518	https://identifiers.org/aop/518	Liver X Receptor (LXR) activation leads to liver steatosis
https://identifiers.org/aop.events/2201	https://identifiers.org/aop.events/2201	https://identifiers.org/aop/520	https://identifiers.org/aop/520	Retinoic acid receptor agonism during neurodevelopment leading to impaired learning and memory
https://identifiers.org/aop.events/2203	https://identifiers.org/aop.events/2203	https://identifiers.org/aop/520	https://identifiers.org/aop/520	Retinoic acid receptor agonism during neurodevelopment leading to impaired learning and memory
https://identifiers.org/aop.events/1392	https://identifiers.org/aop.events/1392	https://identifiers.org/aop/521	https://identifiers.org/aop/521	Essential element imbalance leads to reproductive failure via oxidative stress
https://identifiers.org/aop.events/195	https://identifiers.org/aop.events/195	https://identifiers.org/aop/522	https://identifiers.org/aop/522	Estrogen antagonism leading to increased risk of autism-like behavior
https://identifiers.org/aop.events/2203	https://identifiers.org/aop.events/2203	https://identifiers.org/aop/523	https://identifiers.org/aop/523	Retinoic acid receptor agonism during neurodevelopment leading to microcephaly
https://identifiers.org/aop.events/2201	https://identifiers.org/aop.events/2201	https://identifiers.org/aop/523	https://identifiers.org/aop/523	Retinoic acid receptor agonism during neurodevelopment leading to microcephaly
https://identifiers.org/aop.events/656	https://identifiers.org/aop.events/656	https://identifiers.org/aop/526	https://identifiers.org/aop/526	Decreased, Chicken Ovalbumin Upstream Promoter Transcription Factor II (COUP-TFII) leads to Impaired, Spermatogenesis
https://identifiers.org/aop.events/656	https://identifiers.org/aop.events/656	https://identifiers.org/aop/527	https://identifiers.org/aop/527	Decreased, Chicken Ovalbumin Upstream Promoter Transcription Factor II (COUP-TFII) leads to Hypospadias, increased
https://identifiers.org/aop.events/291	https://identifiers.org/aop.events/291	https://identifiers.org/aop/529	https://identifiers.org/aop/529	Perfluorooctanesulfonic acid (PFOS) binding to peroxisome proliferator-activated receptors (PPARs) causes dysregulation of lipid metabolism and subsequent liver steatosis
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/530	https://identifiers.org/aop/530	Endocytotic lysosomal uptake leads to intestinal barrier disruption
https://identifiers.org/aop.events/55	https://identifiers.org/aop.events/55	https://identifiers.org/aop/530	https://identifiers.org/aop/530	Endocytotic lysosomal uptake leads to intestinal barrier disruption
https://identifiers.org/aop.events/898	https://identifiers.org/aop.events/898	https://identifiers.org/aop/530	https://identifiers.org/aop/530	Endocytotic lysosomal uptake leads to intestinal barrier disruption
https://identifiers.org/aop.events/281	https://identifiers.org/aop.events/281	https://identifiers.org/aop/54	https://identifiers.org/aop/54	Inhibition of Na+/I- symporter (NIS) leads to learning and memory impairment 
https://identifiers.org/aop.events/381	https://identifiers.org/aop.events/381	https://identifiers.org/aop/54	https://identifiers.org/aop/54	Inhibition of Na+/I- symporter (NIS) leads to learning and memory impairment 
https://identifiers.org/aop.events/277	https://identifiers.org/aop.events/277	https://identifiers.org/aop/54	https://identifiers.org/aop/54	Inhibition of Na+/I- symporter (NIS) leads to learning and memory impairment 
https://identifiers.org/aop.events/851	https://identifiers.org/aop.events/851	https://identifiers.org/aop/54	https://identifiers.org/aop/54	Inhibition of Na+/I- symporter (NIS) leads to learning and memory impairment 
https://identifiers.org/aop.events/291	https://identifiers.org/aop.events/291	https://identifiers.org/aop/57	https://identifiers.org/aop/57	AhR activation leading to hepatic steatosis
https://identifiers.org/aop.events/18	https://identifiers.org/aop.events/18	https://identifiers.org/aop/57	https://identifiers.org/aop/57	AhR activation leading to hepatic steatosis
https://identifiers.org/aop.events/167	https://identifiers.org/aop.events/167	https://identifiers.org/aop/58	https://identifiers.org/aop/58	NR1I3 (CAR) suppression leading to hepatic steatosis
https://identifiers.org/aop.events/66	https://identifiers.org/aop.events/66	https://identifiers.org/aop/58	https://identifiers.org/aop/58	NR1I3 (CAR) suppression leading to hepatic steatosis
https://identifiers.org/aop.events/1000	https://identifiers.org/aop.events/1000	https://identifiers.org/aop/6	https://identifiers.org/aop/6	Antagonist binding to PPARα leading to body-weight loss
https://identifiers.org/aop.events/858	https://identifiers.org/aop.events/858	https://identifiers.org/aop/6	https://identifiers.org/aop/6	Antagonist binding to PPARα leading to body-weight loss
https://identifiers.org/aop.events/864	https://identifiers.org/aop.events/864	https://identifiers.org/aop/6	https://identifiers.org/aop/6	Antagonist binding to PPARα leading to body-weight loss
https://identifiers.org/aop.events/998	https://identifiers.org/aop.events/998	https://identifiers.org/aop/6	https://identifiers.org/aop/6	Antagonist binding to PPARα leading to body-weight loss
https://identifiers.org/aop.events/861	https://identifiers.org/aop.events/861	https://identifiers.org/aop/6	https://identifiers.org/aop/6	Antagonist binding to PPARα leading to body-weight loss
https://identifiers.org/aop.events/281	https://identifiers.org/aop.events/281	https://identifiers.org/aop/65	https://identifiers.org/aop/65	XX Inhibition of Sodium Iodide Symporter and Subsequent Adverse Neurodevelopmental Outcomes in Mammals
https://identifiers.org/aop.events/277	https://identifiers.org/aop.events/277	https://identifiers.org/aop/65	https://identifiers.org/aop/65	XX Inhibition of Sodium Iodide Symporter and Subsequent Adverse Neurodevelopmental Outcomes in Mammals
https://identifiers.org/aop.events/656	https://identifiers.org/aop.events/656	https://identifiers.org/aop/66	https://identifiers.org/aop/66	Modulation of Adult Leydig Cell Function Subsequent Glucocorticoid Activation in the Fetal Testis
https://identifiers.org/aop.events/656	https://identifiers.org/aop.events/656	https://identifiers.org/aop/67	https://identifiers.org/aop/67	Modulation of Adult Leydig Cell Function Subsequent to Estradiaol Activation in the Fetal Testis
https://identifiers.org/aop.events/656	https://identifiers.org/aop.events/656	https://identifiers.org/aop/68	https://identifiers.org/aop/68	Modulation of Adult Leydig Cell Function Subsequent to Alterations in the Fetal Testis Protome
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/77	https://identifiers.org/aop/77	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony death/failure 1
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/78	https://identifiers.org/aop/78	Nicotinic acetylcholine receptor activation contributes to abnormal role change within the worker bee caste leading to colony death failure 1
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/79	https://identifiers.org/aop/79	Nicotinic acetylcholine receptor activation contributes to impaired hive thermoregulation and leads to colony loss/failure
https://identifiers.org/aop.events/961	https://identifiers.org/aop.events/961	https://identifiers.org/aop/8	https://identifiers.org/aop/8	Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals
https://identifiers.org/aop.events/281	https://identifiers.org/aop.events/281	https://identifiers.org/aop/8	https://identifiers.org/aop/8	Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/80	https://identifiers.org/aop/80	Nicotinic acetylcholine receptor activation contributes to accumulation of damaged mitochondrial DNA and leads to colony loss/failure
https://identifiers.org/aop.events/177	https://identifiers.org/aop.events/177	https://identifiers.org/aop/87	https://identifiers.org/aop/87	Nicotinic acetylcholine receptor activation contributes to abnormal foraging and leads to colony loss/failure 
https://identifiers.org/aop.events/584	https://identifiers.org/aop.events/584	https://identifiers.org/aop/91	https://identifiers.org/aop/91	Sodium channel inhibition leading to reduced survival
https://identifiers.org/aop.events/584	https://identifiers.org/aop.events/584	https://identifiers.org/aop/93	https://identifiers.org/aop/93	sodium channel inhibition leading to increased predation
https://identifiers.org/aop.events/584	https://identifiers.org/aop.events/584	https://identifiers.org/aop/94	https://identifiers.org/aop/94	Sodium channel inhibition leading to congenital malformations
https://identifiers.org/aop.events/593	https://identifiers.org/aop.events/593	https://identifiers.org/aop/95	https://identifiers.org/aop/95	Ether-a-go-go (ERG) voltage-gated potassium channel inhibition leading to reduced survival
https://identifiers.org/aop.events/619	https://identifiers.org/aop.events/619	https://identifiers.org/aop/97	https://identifiers.org/aop/97	5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to population decline
https://identifiers.org/aop.events/619	https://identifiers.org/aop.events/619	https://identifiers.org/aop/98	https://identifiers.org/aop/98	5-hydroxytryptamine transporter (5-HTT; SERT) inhibition leading to decreased shelter seeking and increased predation
